NZ760903B2 - Disease resistance loci in onion - Google Patents

Abstract

Disclosed is a method of detecting in at least one onion plant a genotype associated with bulb colour, the method comprising the step of: detecting in at least one onion plant an allele of at least one polymorphic nucleic acid that is associated with bulb colour, wherein the polymorphic nucleic acid is in or genetically linked to an onion genomic region defined by the loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6), conferring a red pigment bulb colour. Further disclosed are methods of producing a plant or introgression methods with the phenotype as defined. is in or genetically linked to an onion genomic region defined by the loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6), conferring a red pigment bulb colour. Further disclosed are methods of producing a plant or introgression methods with the phenotype as defined.

Description

NEW ZEALAND Patents Act 1953 Patents Form No. 5 COMPLETE SPECIFICATION Title: DISEASE RESISTANCE LOCI IN ONION Seminis Vegetable Seeds, Inc., of 800 N. Lindbergh Blvd., St. Louis, MO 63167, United States of America (United States), do hereby declare the invention for which we pray that a patent may be granted to us and the method by which it is to be performed, to be particularly described in and by the following statement. Priority is claimed to US 61/909,883 filed 27 November 2013.

FIELD OF THE INVENTION The present invention relates to the field of agriculture and, more specifically, to methods and compositions for producing onion plants with resistance to disease combined with a favorable bulb color.

INCORPORATION OF SEQUENCE LISTING The sequence listing that is contained in the file named "SEMB012USP1_ST25.txt," which is 65 kilobytes as measured in Microsoft Windows operating system and was created on November 27, 2013, is filed electronically herewith and incorporated herein by reference.

BACKGROUND OF THE INVENTION Plant disease resistance is an important trait in plant breeding, particularly for production of food crops. Economically important diseases that affect onion plants include Fusarium Basal Rot (Fusarium oxysporum f. sp. cepae) and Pink Root (Phoma terrestris), among others. These diseases can result in loss of plants, which affects commercial onion crops. Plant breeding efforts have resulted in many onion varieties that are resistant to disease, but such efforts in many cases have been complicated by issues such as genetic linkage, inadequate phenotypic assays, and complex or poorly understood inheritance of traits.

SUMMARY OF THE INVENTION In one aspect, the invention provides an onion plant comprising resistance to Fusarium basal rot and pink root, wherein the plant further comprises lack of the complementary pinks trait. In one embodiment, the onion plant comprises a cis-coupled linkage comprising resistance to Fusarium basal rot conferred by said onion genomic region defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG2), resistance to pink root conferred by said onion genomic region defined by loci NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27) on linkage group 2 (LG2), and lack of the complimentary pinks bulb color conferred by said onion genomic region defined by loci NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29) on linkage group 2 (LG2). In another embodiment, the cis-coupled linkage is introgressed into an onion variety selected from the group consisting of North American Yellow and Universal Yellow. In another embodiment, the invention provides a part of an onion plant comprising resistance to Fusarium basal rot and pink root, wherein the plant further comprises lack of the complementary pinks trait, wherein the part of a plant is further defined as pollen, an ovule, a leaf, an embryo, a root, a root tip, an anther, a flower, a bulb, a stem, a shoot, a seed, a protoplast, a cell, and a callus. In still other embodiments, the onion plant is an agronomically elite line, or a hybrid or an inbred.

In one aspect, the invention provides an onion plant comprising in its genome at least one introgressed allele locus, wherein said introgressed allele locus comprises: an onion genomic region defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG2), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27) on linkage group 2 (LG2), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29) on linkage group 2 (LG2) conferring lack of the Complimentary Pinks bulb color; an onion genomic region defined by loci NQ0258523 (SEQ ID NO:30) and NQ0345206 (SEQ ID NO:36) on linkage group 3 (LG3), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0345564 (SEQ ID NO:38) and NQ0257917 (SEQ ID NO:63) on linkage group 4 (LG4), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0344978 (SEQ ID NO:49) and NQ0344766 (SEQ ID NO:55) on linkage group 4 (LG4), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0258361 (SEQ ID NO:37) and NQ0344778 (SEQ ID NO:61) on linkage group 4 (LG4) conferring production or inhibition of bulb color; or an onion genomic region defined by loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6) conferring a red pigment bulb color; or a progeny plant therefrom. In one embodiment, the onion plant comprises a cis-coupled linkage comprising resistance to Fusarium basal rot (FBR) conferred by said onion genomic region defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG2), resistance to Pink Root conferred by said onion genomic region defined by loci NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27) on linkage group 2 (LG2), and lack of the Complimentary Pinks bulb color conferred by said onion genomic region defined by loci NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29) on linkage group 2 (LG2). In another embodiment, the cis-coupled linkage is introgressed into an onion variety selected from the group consisting of North American Yellow and Universal Yellow.

In another embodiment, a part of the onion plant is defined as pollen, an ovule, a leaf, an embryo, a root, a root tip, an anther, a flower, a bulb, a stem, a shoot, a seed, a protoplast, a cell, and a callus. In other embodiments, the onion plant is an agronomically elite line or a hybrid or an inbred.

In another aspect, the invention provides a method of detecting in at least one onion plant a genotype associated with disease resistance or bulb color, the method comprising the step of: (i) detecting in at least one onion plant an allele of at least one polymorphic nucleic acid that is associated with disease resistance or bulb color, wherein the polymorphic nucleic acid is in or genetically linked to: an onion genomic region defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG2), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27) on linkage group 2 (LG2), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29) on linkage group 2 (LG2) conferring lack of the Complimentary Pinks bulb color; an onion genomic region defined by loci NQ0258523 (SEQ ID NO:30) and NQ0345206 (SEQ ID NO:36) on linkage group 3 (LG3), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0345564 (SEQ ID NO:38) and NQ0257917 (SEQ ID NO:63) on linkage group 4 (LG4), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0344978 (SEQ ID NO:49) and NQ0344766 (SEQ ID NO:55) on linkage group 4 (LG4), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0258361 (SEQ ID NO:37) and NQ0344778 (SEQ ID NO:61) on linkage group 4 (LG4) conferring production or inhibition of bulb color; or an onion genomic region defined by loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6) conferring a red pigment bulb color. In an embodiment, the method further comprises the step of: (ii) selecting at least one onion plant in which a genotype associated with disease resistance or bulb color has been detected. In other embodiments, the onion plant is an agronomically elite line or a hybrid or an inbred, or a progeny plant resulting from the cross of at least one parent plant comprising disease resistance.

In another aspect, the invention provides a method for producing an onion plant that comprises in its genome at least one locus associated with disease resistance or bulb color, the method comprising: (i) crossing a first onion plant lacking a locus associated with disease resistance or bulb color with a second onion plant comprising a locus associated with disease resistance or bulb color defined by: an onion genomic region defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG2), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27) on linkage group 2 (LG2), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29) on linkage group 2 (LG2) conferring lack of the Complimentary Pinks bulb color; an onion genomic region defined by loci NQ0258523 (SEQ ID NO:30) and NQ0345206 (SEQ ID NO:36) on linkage group 3 (LG3), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0345564 (SEQ ID NO:38) and NQ0257917 (SEQ ID NO:63) on linkage group 4 (LG4), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0344978 (SEQ ID NO:49) and NQ0344766 (SEQ ID NO:55) on linkage group 4 (LG4), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0258361 (SEQ ID NO:37) and NQ0344778 (SEQ ID NO:61) on linkage group 4 (LG4) conferring production or inhibition of bulb color; or an onion genomic region defined by loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6) conferring a red pigment bulb color; (ii) detecting in progeny resulting from said crossing at least a first polymorphic locus in or genetically linked to said locus associated with disease resistance or bulb color; and (iii) selecting an onion plant comprising said polymorphism and said locus associated with disease resistance or bulb color. In an embodiment, the method further comprises the step of: (iv) crossing the onion plant of step (iii) with itself or another onion plant to produce a further generation. In another embodiment, steps (iii) and (iv) are repeated from about 3 times to about 10 times. In another embodiment, the onion plant comprises resistance to Fusarium basal rot (FBR) conferred by said onion genomic region defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG2), resistance to Pink Root conferred by said onion genomic region defined by loci NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27) on linkage group 2 (LG2), and lack of the Complimentary Pinks bulb color conferred by said onion genomic region defined by loci NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29) on linkage group 2 (LG2). In other embodiments, the onion plant is an agronomically elite line or a hybrid or an inbred.

Another aspect of the invention provides a method of onion plant breeding, the method comprising the steps of: (i) selecting at least a first onion plant comprising at least one allele of a polymorphic nucleic acid that is in or genetically linked to a QTL associated with disease resistance or bulb color, wherein the QTL maps to: an onion genomic region defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG2), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27) on linkage group 2 (LG2), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29) on linkage group 2 (LG2) conferring lack of the Complimentary Pinks bulb color; an onion genomic region defined by loci NQ0258523 (SEQ ID NO:30) and NQ0345206 (SEQ ID NO:36) on linkage group 3 (LG3), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0345564 (SEQ ID NO:38) and NQ0257917 (SEQ ID NO:63) on linkage group 4 (LG4), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0344978 (SEQ ID NO:49) and NQ0344766 (SEQ ID NO:55) on linkage group 4 (LG4), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0258361 (SEQ ID NO:37) and NQ0344778 (SEQ ID NO:61) on linkage group 4 (LG4) conferring production or inhibition of bulb color; or an onion genomic region defined by loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6) conferring a red pigment bulb color; (ii) crossing the first onion plant with itself or a second onion plant to produce progeny onion plants comprising the QTL associated with disease resistance or bulb color. In one embodiment, at least one polymorphic nucleic acid that is genetically linked to said QTL associated with disease resistance or bulb color maps within 40 cM, 20 cM, 15 cM, 10 cM, 5 cM, or 1 cM of said QTL associated with disease resistance or bulb color.

In another aspect, the invention provides a method of introgressing an allele into an onion plant, the method comprising: (i) genotyping at least one onion plant in a population with respect to at least one polymorphic nucleic acid located in or genetically linked to: an onion genomic region defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG2), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27) on linkage group 2 (LG2), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29) on linkage group 2 (LG2) conferring lack of the Complimentary Pinks bulb color; an onion genomic region defined by loci NQ0258523 (SEQ ID NO:30) and NQ0345206 (SEQ ID NO:36) on linkage group 3 (LG3), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0345564 (SEQ ID NO:38) and NQ0257917 (SEQ ID NO:63) on linkage group 4 (LG4), conferring resistance to Fusarium basal rot (FBR); an onion genomic region defined by loci NQ0344978 (SEQ ID NO:49) and NQ0344766 (SEQ ID NO:55) on linkage group 4 (LG4), conferring resistance to Pink Root (PR); an onion genomic region defined by loci NQ0258361 (SEQ ID NO:37) and NQ0344778 (SEQ ID NO:61) on linkage group 4 (LG4) conferring production or inhibition of bulb color; or an onion genomic region defined by loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6) conferring a red pigment bulb color; (ii) selecting from the population at least one onion plant comprising at least one allele associated with disease resistance or bulb color. In some embodiments, the onion plant is an agronomically elite line or a hybrid or an inbred. In another embodiment, the invention provides an onion plant obtained by such methods.

In another aspect, the invention provides an onion plant comprising resistance to Fusarium basal rot and pink root, wherein the plant further comprises lack of the complementary pinks trait.

BRIEF DESCRIPTION OF THE DRAWINGS Shows a desired haplotype configuration for Universal Yellow onion donor germplasm that is resistant to both Fusarium Basal Rot (FBR) and Pink Root (PR). A 1706 parental allele on chromosome 2 (position 62-63) results in North American Yellow onion germplasm that is resistant to both Fusarium Basal Rot (FBR) and Pink Root (PR).

BRIEF DESCRIPTION OF THE SEQUENCE LISTING SEQ ID NOs:1-74 - Marker sequences used for marker-assisted selection (MAS) of disease resistance and bulb color phenotypes in onion.

SEQ ID NOs:75-115 - Sequences of VIC-labeled probes used for Taqman assays.

SEQ ID NOs:116-156 - Sequences of FAM-labeled probes used for Taqman assays.

SEQ ID NOs:157-197 and 239-240 - Sequences of forward primers used for Taqman assays.

SEQ ID NOs:198-238 - Sequences of reverse primers used for Taqman assays.

DETAILED DESCRIPTION OF THE INVENTION The present invention provides methods and compositions for producing disease resistant onion plants exhibiting resistance to Fusarium Basal Rot (FBR), caused by the fungal pathogen Fusarium oxysporum f. sp. cepae and/or Pink Root (PR), caused by the fungal pathogen Phoma terrestris; while also exhibiting an agronomically desirable bulb color (e.g. yellow), conferred by the lack of a trait called complementary pinks (CP) and/or a bulb color locus identified herein. Methods of breeding and selecting disease resistant onion lines are further provided, as well as plants and plant parts of such disease resistant onions.

Also disclosed herein are molecular markers that are linked to quantitative trait loci ("QTL") contributing to such plant disease resistance. These markers facilitate the use of these loci singly or in any desired loci combination.

Surprisingly, the inventors have been able to develop methods and compositions that allow, for the first time, efficient production of onion plants with specific disease resistance, while avoiding or minimizing the undesirable CP bulb color trait, which had previously been associated with such disease resistance loci. Such traits have previously been unavailable for combination into a single onion plant without the deleterious linkage of disease resistance loci and the undesirable CP trait. The present invention permits production of an onion plant possessing a desired disease resistance trait as described herein without a genetically linked allele causing the CP trait. The ability to combine these traits into a single onion plant is the result of breaking of the linkage between the disease resistance trait and the presence of CP.

In an embodiment of the present invention, breaking linkage between two traits may be accomplished by repeated meiotic events (i.e., recombination) to produce plants with both desired traits. Thus, one embodiment of the current invention provides an onion plant comprising disease resistance and a desired bulb color, wherein the desired bulb color is the result of the absence of an allele conferring CP.

The invention represents a significant advance in the art in that it provides, in certain embodiments, methods and compositions permitting introgression or resistance to selected diseases and combinations of diseases into a commercially desirable genetic background. In specific embodiments of the invention, a QTL conferring resistance to at least one disease including, but not limited to FBR and PR, and lacking CP and/or providing a desirable bulb color, is identified and defined by the map interval bounded by positions in the onion genome that correspond to NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG 2); NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27) on linkage group 2 (LG 2); NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29) on linkage group 2 (LG 2); NQ0258523 (SEQ ID NO:30) and NQ0345206 (SEQ ID NO:36) on linkage group 3 (LG 3); NQ0345564 (SEQ ID NO:38) and NQ0257917 (SEQ ID NO:63) on linkage group 4 (LG 4); NQ0344978 (SEQ ID NO:49) and NQ0344766 (SEQ ID NO:55) on linkage group 4 (LG 4); NQ0258361 (SEQ ID NO:37) and NQ0344778 (SEQ ID NO:61) on linkage group 4 (LG 4); or NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6). The invention further provides an onion plant comprising one or more QTL conferring disease resistance, along with a desirable bulb color, wherein the desirable bulb color may be conferred by lack of CP or by another bulb color locus described herein. In one embodiment, the desirable bulb color in accordance with the invention may be conferred by a lack of the CP locus, a gene in the anthocyanin biosynthesis pathway, a dihydroflavanol 4-reductase (DFR) gene, or other genes or loci known in the art which confer a desired bulb color. In accordance with the present invention, markers within the QTL intervals defined herein may be used to identify disease resistant plants. In a specific embodiment, novel cis-coupling events as described herein may be combined together into a single haplotype of a linkage group, for example on LG2, in order to produce plants with disease resistance together with additional desired traits.

Through use of the corresponding markers provided herein and/or other markers that may be linked thereto, one of skill in the art may use genetic markers to introgress and combine ("stack") disease resistance traits or other desirable traits in commercially relevant onion lines. In a specific embodiment, onion plants according to the invention may be crossed to produce hybrid onion plants or varieties that comprise the desired traits.

In accordance with the invention, identified disease resistance QTL may be introgressed into any onion genetic background. In an embodiment, onion lines comprising a commercially favorable bulb color, such as a yellow bulb, including North American yellow or Universal Yellow for example, may be used for introgression of QTL conferring disease resistance combined with any additional desirable trait such as bulb color and/or lack of CP.

Thus, using the methods of the invention and starting from any genetic sources identified herein or available in the art, an onion plant of any genotype may be produced that further comprises the desired disease resistance, including FBR and PR, coupled with any additional traits. In addition, such plants may be prepared to comprise other desired traits, for example elite agronomic traits.

Certain embodiments further provide methods of detecting in an onion plant a genotype associated with disease resistance, which may be coupled with a desired bulb color.

Certain embodiments also provide methods of identifying and selecting an onion plant comprising in its genome a genotype associated with disease resistance coupled with a desired bulb color. Further embodiments provide methods of producing an onion plant that comprises in its genome at least one introgressed locus associated with disease resistance coupled with a desired bulb color and methods for introgressing such alleles into a given onion variety. Onion plants and parts thereof made by any of said methods are also provided for, as well as polymorphic nucleic acid sequences that may be used in the production and identification of such plants. In an embodiment, the invention provides a food product comprising such an onion plant or a bulb or other plant part of such a plant.

By providing markers to obtain a phenotype of interest, such as disease resistance, or disease resistance coupled with a desired bulb color, the invention results in significant economization by allowing replacement of costly, time-intensive, and potentially unreliable phenotyping assays. Further, breeding programs can be designed to explicitly drive the frequency of specific favorable phenotypes by targeting particular genotypes. Fidelity of these associations may be monitored continuously to ensure maintained predictive ability and informed breeding decisions.

In accordance with the invention, one of skill in the art may identify a candidate germplasm source possessing a desirable disease resistance phenotype coupled with a desired bulb color phenotype as described herein. The techniques of the present invention may be used to identify desirable disease-resistant phenotypes coupled with a desired bulb color by identifying genetic markers associated with such a phenotype or phenotypes, or such techniques may employ phenotypic assays to identify desired plants either alone or in combination with genetic assays, thereby also identifying a marker genotype associated with the trait that may be used for production of new varieties with the methods described herein.

The invention provides for the introgression of at least a first locus conferring disease resistance coupled with a desired bulb color into a given genetic background. Successful onion production depends on attention to various horticultural practices. These include soil management with special attention to proper fertilization, crop establishment with appropriate spacing, weed control, and the introduction of bees or other insects for pollination, irrigation, and pest management. Onion crops can be established from seed or from starter bulbs, among other methods known in the art. Starter bulbs can result in an earlier crop compared with a crop produced from direct seeding.

Development of Onion Plants With Disease Resistance Coupled with a Desired Bulb Color The present disclosure identifies quantitative trait loci (QTL) with major influence on disease resistance of onion plants and QTL with major influence on bulb color, as well as markers genetically linked to and predictive of such loci that can be used for the tracking and introgression of the QTL into desirable germplasm, such as by marker-assisted selection (MAS) and/or marker-assisted backcrossing. The invention also provides for introgression of a single locus conferring disease resistance coupled with a desirable bulb color. Such desirable bulb color may be conferred by a bulb color locus as described herein or known in the art or by a lack of a locus for CP. An onion plant of the present invention may also be produced by introgressing one or more QTL conferring disease resistance into an onion plant comprising a desired bulb color to produce an onion plant with both disease resistance and desired bulb color.

As described in the Examples, five QTL were identified for disease resistance to FBR and PR, along with three loci controlling bulb color and/or CP. One of these color loci was found to colocalize with a marker in a candidate gene from the anthocyanin biosynthesis pathway. The main effect QTL for both FBR and PR localized to a similar region on LG2, where one of the loci for complementary pinks has also been localized. These mapping results verify a linkage of FBR, PR, and the CP trait, and why it has been difficult to combine resistance of these diseases without CP during onion breeding. QTL intervals and markers for these disease traits may now be used to develop new onion lines and varieties. In an embodiment, novel cis-coupling linkages, for example on LG2 as described herein, allows the combination of disease resistance in donor onion lines such as North American yellow and Universal Yellow, among others.

The present invention contemplates the tracking and introduction of such QTL and any combinations thereof into a given genetic background. One of ordinary skill will understand that resistance to one or more diseases conferred by this QTL may be introgressed from one genotype to another using a locus described herein via MAS. Accordingly, an onion germplasm source can be selected that has resistance to one or more diseases. Using this QTL, a breeder may select an onion plant with resistance to disease or with resistance to disease coupled with a desirable bulb color, or track such phenotypes during breeding using MAS for the region described herein. Provided with the present disclosure, one of ordinary skill can introduce resistance to one or more diseases coupled with desired bulb color into any genetic background.

QTL identified herein may be used for MAS for resistance to one or more diseases coupled with a desired bulb color in onion. This discovery of a QTL associated with disease resistance coupled with a desired bulb color may facilitate the development of commercially valuable onion plants or varieties thereof having resistance to multiple diseases.

For most breeding objectives, commercial breeders may work within germplasm that is often referred to as the "cultivated type" or "elite." This germplasm is easier to use in plant breeding because it generally performs well when evaluated for horticultural performance.

The performance advantage a cultivated type provides is sometimes offset by a lack of allelic diversity. This is the tradeoff a breeder accepts when working with cultivated germplasm— better overall performance, but a lack of allelic diversity. Breeders generally accept this tradeoff because progress is faster when working with cultivated material than when breeding with genetically diverse sources.

In contrast, when a breeder makes either intra-specific crosses, or inter-specific crosses, a converse trade off occurs. In these examples, a breeder typically crosses cultivated germplasm with a non-cultivated type. In such crosses, the breeder may gain access to novel alleles from the non-cultivated type, but may have to overcome the genetic drag associated with the donor parent. Because of the difficulty with this breeding strategy, this approach often fails because of fertility and fecundity problems. The difficulty with this breeding approach extends to many crops, and is exemplified with an important disease-resistant phenotype that was first described in tomato in 1944 (Smith, Proc. Am. Soc. Hort. Sci. 44:413-16). In this cross, nematode disease resistance was transferred from L. peruvianum (PI128657) into a cultivated tomato. Despite intensive breeding, it was not until the mid- 1970’s before breeders could overcome the genetic drag and release successful lines carrying this trait. Indeed, even today, tomato breeders deliver this disease resistance gene to a hybrid variety from only one parent.

To date, the process of introgressing novel resistance genes into acceptable commercial types is a long and often arduous process and can be difficult because the trait may be polygenic, or have low heritability, or have linkage drag or some combination thereof. While some phenotypes are determined by the genotype at one locus, most variation observed in nature is continuous. Unlike simply inherited traits, continuous variation can be the result of polygenic inheritance, and may be difficult to track. Loci that affect continuous variation are referred to as QTL. Variation in the phenotype of a quantitative trait is the result of the allelic composition at the QTL and the environmental effect. The heritability of a trait is the proportion of the phenotypic variation attributed to the genetic variance, which varies between 0 and 1.0. Thus, a trait with heritability near 1.0 is not greatly affected by the environment. Those skilled in the art recognize the importance of creating commercial lines with high heritability horticultural traits because these cultivars will allow growers to produce a crop with uniform market specifications.

Genomic Region, QTL, Polymorphic Nucleic Acids, and Alleles Associated With Disease Resistance and Favorable Bulb Color in Onion Markers useful for the present invention can be designed from the onion genome.

Duangjit et al. published the most recent publicly available genetic map of the onion genome (Theor Appl Genet 126(8):2093-2101, 2013). Applicants have discovered genomic regions, QTL, alleles, polymorphic nucleic acids, linked markers, and the like that when present in certain allelic forms are associated with disease resistance and favorable bulb color in onion.

Using the methods outlined herein, QTL were identified in onion for resistance to Fusarium Basal Rot (FBR) and Pink Root (PR), while also exhibiting a favorable bulb color. Genomic regions associated with such traits were located at onion linkage group 2 (LG2) defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23); at LG2 defined by loci NQ0257277 (SEQ ID NO:22) and NQ0258453 (SEQ ID NO:27); at LG2 defined by loci NQ0257220 (SEQ ID NO:26) and NQ0257692 (SEQ ID NO:29); at LG3 defined by loci NQ0258523 SEQ ID NO:30) and NQ0345206 SEQ ID NO:36); at LG4 defined by loci NQ0345564 SEQ ID NO:38) and NQ0257917 SEQ ID NO:63); at LG4 defined by loci NQ0344978 SEQ ID NO:49) and NQ0344766 SEQ ID NO:55); at LG 4 defined by loci NQ0258361 SEQ ID NO:37) and NQ0344778 SEQ ID NO:61); or at LG6 defined by loci NQ0257378 SEQ ID NO:64) and NQ0345734 SEQ ID NO:74).

Certain of the various embodiments of the present disclosure utilize a QTL or polymorphic nucleic acid marker or allele located at or within such genomic regions.

Flanking markers on LG2 that identify a genomic region associated with resistance to multiple diseases or favorable bulb color include NQ0345038 (SEQ ID NO:3) and NQ0257692 (SEQ ID NO:29). Intervening markers on LG2 that identify a genomic region associated with resistance to multiple diseases or favorable bulb color may include at least any of SEQ ID NOs:4-28. Flanking markers on LG3 that identify a genomic region associated with resistance to disease or favorable bulb color include NQ0258523 (SEQ ID NO:30) and NQ0345206 (SEQ ID NO:36). Intervening markers on LG3 that identify a genomic region associated with resistance to disease or favorable bulb color may include at least any of SEQ ID NOs:31-35. Flanking markers on LG4 that identify a genomic region associated with resistance to multiple diseases or favorable bulb color include NQ0258361 (SEQ ID NO:37) and NQ0257917 (SEQ ID NO:63). Intervening markers on LG4 that identify a genomic region associated with resistance to multiple diseases or favorable bulb color may include at least any of SEQ ID NOs:38-62. Flanking markers on LG6 that identify a genomic region associated with resistance to disease or favorable bulb color include NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74). Intervening markers on LG6 that identify a genomic region associated with resistance to disease or favorable bulb color may include at least any of SEQ ID NOs:65-73. These genomic regions, or subregions thereof, associated with disease resistance and/or favorable bulb color can be described as being flanked by or defined by any of the markers described herein, although one of skill will recognize that additional markers may be used, as well.

The above markers and allelic states are exemplary. One of skill in the art would recognize how to identify onion plants with other polymorphic nucleic acid markers and allelic states thereof related to disease resistance or desirable bulb color in onion consistent with the present disclosure. One of skill in the art would also know how to identify the allelic state of other polymorphic nucleic acid markers located in the genomic region(s) or linked to the QTL or other markers identified herein, to determine their association with disease resistance or desirable bulb color in onion.

One of skill in the art would understand that polymorphic nucleic acids that are located in the genomic region(s) identified may be used in certain embodiments of the methods of the invention. Given the provisions herein of a genomic region, QTL, and polymorphic markers identified herein, additional markers located either within or near a genomic region described herein that are associated with the phenotype may be obtained by typing new markers in various germplasm. The genomic region, QTL, and polymorphic markers identified herein can also be mapped relative to any publicly available physical or genetic map to place the region described herein on such map. One of skill in the art would also understand that additional polymorphic nucleic acids that are genetically linked to the QTL associated with disease resistance or desirable bulb color in onion and that map within about 40 cM, 20 cM, 10 cM, 5 cM, or 1 cM of the QTL or the markers associated with disease resistance or desirable bulb color in onion may also be used.

Introgression of a Genomic Locus Associated with Disease Resistance and/or Desirable Bulb Color in Onion Provided herein are onion plants comprising one or more introgressed genomic regions associated with disease resistance and/or desirable bulb color and methods of obtaining the same. Marker-assisted introgression involves the transfer of a chromosomal region, defined by one or more markers, from one germplasm to a second germplasm.

Offspring of a cross that contain the introgressed genomic region can be identified by the combination of markers characteristic of the desired introgressed genomic region from a first germplasm (e.g., germplasm with disease resistance or desirable bulb color in onion) and both linked and unlinked markers characteristic of the desired genetic background of a second germplasm.

Flanking markers that fall on both the telomere proximal end and the centromere proximal end of any of these genomic intervals may be useful in a variety of breeding efforts that include, but are not limited to, introgression of genomic regions associated with disease resistance coupled with a desirable bulb color in onion into a genetic background comprising markers associated with germplasm that ordinarily contains a genotype associated with another phenotype.

Markers that are linked and either immediately adjacent or adjacent to the identified disease resistance and/or desirable bulb color QTL that permit introgression of the QTL in the absence of extraneous linked DNA from the source germplasm containing the QTL are provided herewith. Those of skill in the art will appreciate that when seeking to introgress a smaller genomic region comprising a QTL associated with disease resistance and/or desirable bulb color in onion described herein, that any of the telomere proximal or centromere proximal markers that are immediately adjacent to a larger genomic region comprising the QTL can be used to introgress that smaller genomic region.

A marker within about 40 cM of a marker of a disease resistance QTL or desirable bulb color QTL described herein, for example, may be useful in a variety of breeding efforts that include, but are not limited to, introgression of genomic regions associated with disease resistance coupled with a desirable bulb color in onion into a genetic background comprising markers associated with germplasm that ordinarily contains a genotype associated with another phenotype. For example, a marker within 40 cM, 20 cM, 15 cM, 10 cM, 5cM, 2 cM, or 1 cM or less of a disease resistance QTL or desirable bulb color QTL or marker described herein can be used for marker-assisted introgression of disease resistance coupled with a desirable bulb color in onion.

A marker in linkage disequilibrium with a disease resistance or desirable bulb color phenotype QTL marker on LG2, LG3, LG4, and/or LG6 described herein can thus be used for marker-assisted introgression of disease resistance or desirable bulb color in onion. For example, a marker within 40 cM, 20 cM, 15 cM, 10 cM, 5cM, 2 cM, or 1 cM of a disease resistance or desirable bulb color QTL marker on LG2, LG3, LG4, and/or LG6 as described herein can be used for marker-assisted introgression of disease resistance or desirable bulb color. As described above, a disease resistance or desirable bulb color QTL marker on LG2, LG3, LG4, and/or LG6 may include one or more of SEQ ID NO:1-74 or any loci or sub- regions described herein, as well as other known markers in those same regions and that are genetically linked thereto.

Molecular Assisted Breeding Techniques Genetic markers that can be used in the practice of the present invention include, but are not limited to, Restriction Fragment Length Polymorphisms (RFLP), Amplified Fragment Length Polymorphisms (AFLP), Simple Sequence Repeats (SSR), simple sequence length polymorphisms (SSLPs), Single Nucleotide Polymorphisms (SNP), Insertion/Deletion Polymorphisms (Indels), Variable Number Tandem Repeats (VNTR), and Random Amplified Polymorphic DNA (RAPD), isozymes, and others known to those skilled in the art. Marker discovery and development in crops provides the initial framework for applications to marker-assisted breeding activities (U.S. Patent Pub. Nos.: 2005/0204780, 2005/0216545, 2005/0218305, and 2006/00504538). The resulting "genetic map" is the representation of the relative position of characterized loci (polymorphic nucleic acid markers or any other locus for which alleles can be identified) to each other.

Polymorphisms comprising as little as a single nucleotide change can be assayed in a number of ways. For example, detection can be made by electrophoretic techniques including a single strand conformational polymorphism (Orita et al., Genomics 8(2):271-278, 1989), denaturing gradient gel electrophoresis (Myers, EPO 0273085, 1985), or cleavage fragment length polymorphisms (Life Technologies, Inc., Gathersberg, MD 20877), but the widespread availability of DNA sequencing machines often makes it easier to just sequence amplified products directly. Once the polymorphic sequence difference is known, rapid assays can be designed for progeny testing, typically involving some version of PCR amplification of specific alleles (PASA, Sommer, et al., Biotechniques 12(1):82-87, 1992), or PCR amplification of multiple specific alleles (PAMSA, Dutton and Sommer, Biotechniques, 11(6):700-7002, 1991).

As a set, polymorphic markers serve as a useful tool for fingerprinting plants to inform the degree of identity of lines or varieties (U.S. Patent No. 6,207,367). These markers form the basis for determining associations with phenotypes and can be used to drive genetic gain. In certain embodiments of methods of the invention, polymorphic nucleic acids can be used to detect in an onion plant a genotype associated with disease resistance coupled with a desirable bulb color, identify an onion plant with a genotype associated with disease resistance coupled with a desirable bulb color, and to select an onion plant with a genotype associated with disease resistance coupled with a desirable bulb color. In certain embodiments of methods of the invention, polymorphic nucleic acids can be used to produce an onion plant that comprises in its genome an introgressed locus associated with disease resistance coupled with a desirable bulb color. In certain embodiments of the invention, polymorphic nucleic acids can be used to breed progeny onion plants comprising a locus associated with disease resistance coupled with a desirable bulb color.

Certain genetic markers may include "dominant" or "codominant" markers.

"Codominant" markers reveal the presence of two or more alleles (two per diploid individual). "Dominant" markers reveal the presence of only a single allele. Markers are preferably inherited in codominant fashion so that the presence of both alleles at a diploid locus, or multiple alleles in triploid or tetraploid loci, are readily detectable, and they are free of environmental variation, i.e., their heritability is 1. A marker genotype typically comprises two marker alleles at each locus in a diploid organism. The marker allelic composition of each locus can be either homozygous or heterozygous. Homozygosity is a condition where both alleles at a locus are characterized by the same nucleotide sequence. Heterozygosity refers to different conditions of the allele at a locus.

Nucleic acid-based analyses for determining the presence or absence of the genetic polymorphism (i.e. for genotyping) can be used in breeding programs for identification, selection, introgression, and the like. A wide variety of genetic markers for the analysis of genetic polymorphisms are available and known to those of skill in the art. The analysis may be used to select for genes, portions of genes, QTL, alleles, or genomic regions that comprise or are linked to a genetic marker that is linked to or associated with a disease resistance or desirable bulb color phenotype.

As used herein, nucleic acid analysis methods include, but are not limited to, PCR- based detection methods (for example, TaqMan assays), microarray methods, mass spectrometry-based methods and/or nucleic acid sequencing methods, including whole genome sequencing. In certain embodiments, the detection of polymorphic sites in a sample of DNA, RNA, or cDNA may be facilitated through the use of nucleic acid amplification methods. Such methods specifically increase the concentration of polynucleotides that span the polymorphic site, or include that site and sequences located either distal or proximal to it.

Such amplified molecules can be readily detected by gel electrophoresis, fluorescence detection methods, or other means.

The use of TaqMan probes in PCR is known in the art (see, for example, Holland et al., PNAS 88:7276-7280, 1991) and allows for increased specificity of PCR assays by fluorophore-based detection. In an embodiment of the invention, TaqMan probes such as those set forth in Table 3 can be used to detect SNPs conferring disease resistance. TaqMan assays use two specific primers that target a region flanking a SNP site and two fluorescent probes, each labeled with a different fluorophore (VIC or 6-FAM) covalently linked to the 5' end of the probe. A non-fluorescent quencher near the 3’ end prevents liberation of the fluorescence if the probe is not degraded. During PCR, probes that hybridize specifically to DNA fragments are destroyed and the fluorescence of corresponding fluorophore is liberated.

One method of achieving such amplification employs the polymerase chain reaction (PCR) (Mullis et al. 1986 Cold Spring Harbor Symp. Quant. Biol. 51:263-273; European Patent 50,424; European Patent 84,796; European Patent 258,017; European Patent 237,362; European Patent 201,184; U.S. Patent 4,683,202; U.S. Patent 4,582,788; and U.S. Patent 4,683,194), using primer pairs that are capable of hybridizing to the proximal sequences that define a polymorphism in its double-stranded form. Methods for typing DNA based on mass spectrometry can also be used. Such methods are disclosed in US Patents 6,613,509 and 6,503,710, and references found therein.

Polymorphisms in DNA sequences can be detected or typed by a variety of effective methods well known in the art including, but not limited to, those disclosed in U.S. Patent Nos. 5,468,613, 5,217,863; 5,210,015; 5,876,930; 6,030,787; 6,004,744; 6,013,431; ,595,890; 5,762,876; 5,945,283; 5,468,613; 6,090,558; 5,800,944; 5,616,464; 7,312,039; 7,238,476; 7,297,485; 7,282,355; 7,270,981 and 7,250,252 all of which are incorporated herein by reference in their entireties. However, the compositions and methods of the present invention can be used in conjunction with any polymorphism typing method to type polymorphisms in genomic DNA samples. These genomic DNA samples used include but are not limited to genomic DNA isolated directly from a plant, cloned genomic DNA, or amplified genomic DNA.

For instance, polymorphisms in DNA sequences can be detected by hybridization to allele-specific oligonucleotide (ASO) probes as disclosed in U.S. Patent Nos. 5,468,613 and ,217,863. U.S. Patent No. 5,468,613 discloses allele specific oligonucleotide hybridizations where single or multiple nucleotide variations in nucleic acid sequence can be detected in nucleic acids by a process in which the sequence containing the nucleotide variation is amplified, spotted on a membrane and treated with a labeled sequence-specific oligonucleotide probe.

Target nucleic acid sequence can also be detected by probe ligation methods as disclosed in U.S. Patent No. 5,800,944 where sequence of interest is amplified and hybridized to probes followed by ligation to detect a labeled part of the probe.

Microarrays can also be used for polymorphism detection, wherein oligonucleotide probe sets are assembled in an overlapping fashion to represent a single sequence such that a difference in the target sequence at one point would result in partial probe hybridization (Borevitz et al., Genome Res. 13:513-523, 2003; Cui et al., Bioinformatics 21:3852-3858, 2005). On any one microarray, it is expected there will be a plurality of target sequences, which may represent genes and/or noncoding regions wherein each target sequence is represented by a series of overlapping oligonucleotides, rather than by a single probe. This platform provides for high throughput screening of a plurality of polymorphisms. Typing of target sequences by microarray-based methods is disclosed in U.S. Patent Nos. 6,799,122; 6,913,879; and 6,996,476.

Target nucleic acid sequence can also be detected by probe linking methods as disclosed in U.S. Patent No. 5,616,464, employing at least one pair of probes having sequences homologous to adjacent portions of the target nucleic acid sequence and having side chains which non-covalently bind to form a stem upon base pairing of the probes to the target nucleic acid sequence. At least one of the side chains has a photoactivatable group which can form a covalent cross-link with the other side chain member of the stem.

Other methods for detecting SNPs and Indels include single base extension (SBE) methods. Examples of SBE methods include, but are not limited, to those disclosed in U.S.

Patent Nos. 6,004,744; 6,013,431; 5,595,890; 5,762,876; and 5,945,283. SBE methods are based on extension of a nucleotide primer that is adjacent to a polymorphism to incorporate a detectable nucleotide residue upon extension of the primer. In certain embodiments, the SBE method uses three synthetic oligonucleotides. Two of the oligonucleotides serve as PCR primers and are complementary to sequence of the locus of genomic DNA which flanks a region containing the polymorphism to be assayed. Following amplification of the region of the genome containing the polymorphism, the PCR product is mixed with the third oligonucleotide (called an extension primer) which is designed to hybridize to the amplified DNA adjacent to the polymorphism in the presence of DNA polymerase and two differentially labeled dideoxynucleosidetriphosphates. If the polymorphism is present on the template, one of the labeled dideoxynucleosidetriphosphates can be added to the primer in a single base chain extension. The allele present is then inferred by determining which of the two differential labels was added to the extension primer. Homozygous samples will result in only one of the two labeled bases being incorporated and thus only one of the two labels will be detected. Heterozygous samples have both alleles present, and will thus direct incorporation of both labels (into different molecules of the extension primer) and thus both labels will be detected.

In another method for detecting polymorphisms, SNPs and Indels can be detected by methods disclosed in U.S. Patent Nos. 5,210,015; 5,876,930; and 6,030,787 in which an oligonucleotide probe having a 5’ fluorescent reporter dye and a 3’ quencher dye covalently linked to the 5’ and 3’ ends of the probe. When the probe is intact, the proximity of the reporter dye to the quencher dye results in the suppression of the reporter dye fluorescence, e.g. by Forster-type energy transfer. During PCR, forward and reverse primers hybridize to a specific sequence of the target DNA flanking a polymorphism while the hybridization probe hybridizes to polymorphism-containing sequence within the amplified PCR product. In the subsequent PCR cycle DNA polymerase with 5’  3’ exonuclease activity cleaves the probe and separates the reporter dye from the quencher dye resulting in increased fluorescence of the reporter.

In another embodiment, the locus or loci of interest can be directly sequenced using nucleic acid sequencing technologies. Methods for nucleic acid sequencing are known in the art and include technologies provided by 454 Life Sciences (Branford, CT), Agencourt Bioscience (Beverly, MA), Applied Biosystems (Foster City, CA), LI-COR Biosciences (Lincoln, NE), NimbleGen Systems (Madison, WI), Illumina (San Diego, CA), and VisiGen Biotechnologies (Houston, TX). Such nucleic acid sequencing technologies comprise formats such as parallel bead arrays, sequencing by ligation, capillary electrophoresis, electronic microchips, "biochips," microarrays, parallel microchips, and single-molecule arrays, as reviewed by R.F. Service Science 2006 311:1544-1546.

The markers to be used in the methods of the present invention should preferably be diagnostic of origin in order for inferences to be made about subsequent populations.

Experience to date suggests that SNP markers may be ideal for mapping because the likelihood that a particular SNP allele is derived from independent origins in the extant populations of a particular species is very low. As such, SNP markers appear to be useful for tracking and assisting introgression of QTLs.

Definitions The following definitions are provided to better define the present invention and to guide those of ordinary skill in the art in the practice of the present invention. Unless otherwise noted, terms are to be understood according to conventional usage by those of ordinary skill in the relevant art.

As used herein, a "desired bulb color" or "desirable bulb color" or "favorable bulb color" refers to an onion bulb that exhibits a commercially acceptable color such as yellow, and/or that lacks a deleterious or undesirable color, such as that conferred by complementary pinks (CP).

As used herein, the term "plant" includes plant cells, plant protoplasts, plant cells of tissue culture from which onion plants can be regenerated, plant calli, plant clumps and plant cells that are intact in plants or parts of plants such as pollen, flowers, seeds, leaves, stems, and the like.

As used herein, the term "population" means a genetically heterogeneous collection of plants that share a common parental derivation.

As used herein, the terms "variety" and "cultivar" mean a group of similar plants that by their genetic pedigrees and performance can be identified from other varieties within the same species.

As used herein, an "allele" refers to one of two or more alternative forms of a genomic sequence at a given locus on a chromosome.

A "Quantitative Trait Locus (QTL)" is a chromosomal location that encodes for at least a first allele that affects the expressivity of a phenotype.

As used herein, "repulsion" or "repulsion phase" refers to the inheritance of alleles from two genes, where the desired allele at each of the two genetic loci are found on different homologous chromosomes. This may also be referred to as a "trans" configuration of alleles.

As used herein, a "marker" means a detectable characteristic that can be used to discriminate between organisms. Examples of such characteristics include, but are not limited to, genetic markers, biochemical markers, metabolites, morphological characteristics, and agronomic characteristics.

As used herein, the term "phenotype" means the detectable characteristics of a cell or organism that can be influenced by gene expression.

As used herein, the term "genotype" means the specific allelic makeup of a plant.

As used herein, the term "introgressed," when used in reference to a genetic locus, refers to a genetic locus that has been introduced into a new genetic background, such as through backcrossing. Introgression of a genetic locus can thus be achieved through plant breeding methods and/or by molecular genetic methods. Such molecular genetic methods include, but are not limited to, various plant transformation techniques and/or methods that provide for homologous recombination, non-homologous recombination, site-specific recombination, and/or genomic modifications that provide for locus substitution or locus conversion.

As used herein, the term "linked," when used in the context of nucleic acid markers and/or genomic regions, means that the markers and/or genomic regions are located on the same linkage group or chromosome such that they tend to segregate together at meiosis.

As used herein, the term "denoting" when used in reference to a plant genotype refers to any method whereby a plant is indicated to have a certain genotype. This includes any means of identification of a plant having a certain genotype. Indication of a certain genotype may include, but is not limited to, any entry into any type of written or electronic medium or database whereby the plant’s genotype is provided. Indications of a certain genotype may also include, but are not limited to, any method where a plant is physically marked or tagged.

Illustrative examples of physical marking or tags useful in the invention include, but are not limited to, a barcode, a radio-frequency identification (RFID), a label, or the like.

EXAMPLES The following disclosed embodiments are merely representative of the invention which may be embodied in various forms. Thus, specific structural, functional, and procedural details disclosed in the following examples are not to be interpreted as limiting.

Example 1 Disease mapping in onion A large F2:3 mapping population (approximately 620 families, selectively phenotyped across diseases) from the origin onion line SYG1706/Serrana was created and phenotyped for various traits. This resulted in the identification of QTL for two important diseases in Onion: Fusarium Basal Rot (FBR) and Pink Root (PR). Several major QTL for these traits were identified (Table 1), based on phenotyping conducted in Deforest, WI (inoculated seedling growth chamber test for FBR and PR) and Donna, TX (mature plant/bulb field evaluation for PR). Most notably, FBR and PR resistance mapped in repulsion phase to a similar region on linkage group 2 (LG2), in a genetic location where a third detrimental trait for complementary pinks (mapping to position 62.5 on LG2) has also been mapped in this population. This repulsion linkage with complementary pinks was considered as a reason FBR resistance from the landrace donor Serrana has been very difficult to breed into elite onion germplasm. An effort was thus undertaken to link FBR resistance, PR resistance, and a bulb color locus in the correct phase for simultaneous introgression into breeding programs. Identified QTL from this effort are given in Table 1 below.

Table 1. Summary of Significant QTL Detected for Onion Disease and Color Traits.

Linkag Resistanc Group 1-LOD 2-LOD Additiv e donor LO Trait (LG) interva interva Most significant marker/s e effect parent D locatio l (cM) l (cM) (%) allele positio Serrana LG 2 : 14.7 41.9 – 40.9 – NQ0258383 6.8 46.9 54.9 61.9 FBR Serrana LG 3 : 4.6 38.1 – 34.1 – NQ0257455 2.3 52.1cM 60.9 86.1 FBR Serrana LG 4 : 2.8 22.7 – 21.7– NQ0257799 3.3 44.8 92.7 101.7 PR SYG LG 2 : 17.7 53.9 – 53.5 – NQ0257570 32.4 1706 57.9 60.9 61.9 Serrana LG 4 : 5.8 46.7 – 38.7 – NQ0345680 10.8 51.7 56.3 60.7 Bulb LG 6 : 4.6 – 33.6* NACEP009089369*, 22 cM NQ0258009*, NQ0344415*, Colo r NACEP009090969* Bulb LG 4 : 17.0 – 82.8* NQ0344496*, NQ0345333* Colo 52.0- 53.6 LG4 cM Bulb LG 2 : NQ0258453*, Colo 62.5- NACEP009407370/NQ025746 63.1 1* LG2 cM "*" denotes significance at p-value<0.05 In addition to the above QTL study, PR resistance was mapped as a binary trait in the same population (SYG1706/Serrana), as it behaves as expected for a single gene under incomplete dominant control. Binary mapping confirmed the position of PR resistance on LG2 at 56.3 cM.

Example 2 Bulb color mapping in onion Three loci controlling color in onion were mapped to LG2, LG4, and LG6.

Complementary Pinks (CP), which has been reported to be controlled by two epistatic loci, was mapped to LG6 and LG2 in the same SYG1706/Serrana population as described in Example 1. Complementary Pinks is a bulb color phenomenon that manifests itself in wide crosses involving elite onion lines and certain more exotic germplasm. This traditionally has created a barrier to accessing certain disease resistances, such as FBR, which is present in Brazilian onion landraces such as Serrana. The CP loci were mapped as a binary trait (yellow vs. pink bulb phenotype) to the positions of LG6: ~22.4cM and LG2:~62.5cM. A candidate gene marker based off of the dihydroflavonol 4-reductase (DFR) gene was developed and maps to the same region on LG6 and is suspected to be the R locus controlling bulb color.

In a second, elite x elite F2 mapping population (SWL14197-DH/HRL 5225B) segregating for bulb color (segregating for yellow, white, red, pink bulbs), two QTL were identified for bulb color. Parent SWL14197 is white-bulbed, and HRL5225B is red-bulbed. A QTL on LG4 at ~53 cM appears to control the production/inhibition of color pigments, while the QTL on LG6 at ~22.4 cM gene appears to control red pigment production.

The LG6 loci for color of both CP and bulb color appears to be the same in both populations/traits, and is likely the R locus or DFR gene on which a marker from this candidate gene for the anthocyanin biosynthesis pathway maps (NACEP009089369 and NACEP009090969, mapping to LG6: 22.3 cM and 22.6 cM, respectively).

Example 3 Cis-Coupling Linkage of FBR, PR, and color Within the SYG1706/Serrana F2:3 population, the opportunity exists to combine FBR resistance with PR resistance, in both a North American yellow and Universal yellow onion line. With the identification of the major QTL/genes underlying color and disease resistance, phenotype and genotype information can be used to identify those recombinant families that can be used to couple the traits. Novel cis-coupling events have been identified, that have combined multiple disease resistances together onto a continuous haplotype stretch of linkage group 2. Based on the QTL information, the following haplotype is considered the most desirable configuration for obtaining a high level of FBR and PR resistance in a universal yellow bulb (i.e. a single onion line with resistance to FBR, PR, and a lack of CP).

A universal yellow bulb is beneficial because it can be crossed with both North American and South American germplasm, and not produce (complementary) pink bulbs. A double recombination event on LG2 is required to obtain this phenotype (. A North American yellow donor is also desirable, as this germplasm will not produce CP when crossed to North American germplasm. A North America yellow is defined by a 1706 allele on LG2 (position 62-63), and only requires a single recombination on linkage group 2.

Thus, five QTL for disease resistance to FBR and PR, along with three loci controlling bulb color and/or CP were identified. One of these color loci was found to colocalize with a marker in a candidate gene from the anthocyanin biosynthesis pathway.

The main effect QTL for both FBR and PR localized to a similar region on LG2, where one of the loci for complementary pinks has also been placed. These mapping results verify the suspected linkage of FBR, PR and complementary pinks, and thus why it has been difficult to combine all traits in breeding. Overall, this information provides insight into genetic control of these key onion traits, and now allows a more controlled approach to combining all traits into elite onion lines. QTL intervals and markers for these disease traits have been enabled for use in new developmental crosses and resulting segregating populations in a HAPQTL MAS approach. Further, event creation may enable the creation of novel cis-coupling linkages on LG2 to combine FBR and PR resistance in both a North American yellow and Universal Yellow bulbed donor. Recombination events combining FBR and PR in a North American yellow have also been accomplished.

Example 4 Marker Details for Marker-Assisted Selection Based on the QTL results and intervals, markers have been provided herein for important disease resistance loci for a HAP QTL approach in new developmental crosses. As outlined in onion breeding is amenable to a HAP QTL approach. Since developmental cross cages are composed of a single plant x single plant crossing pattern, parental marker genotypes for each plant going into a respective developmental cross can be obtained. Parental genotypes can be obtained using a core set of markers that are in trait regions that are considered potential targets for marker-assisted selection (MAS) (identified as "Master Loci" in . Therefore, per cage, a select number of the same polymorphic markers (identified on a bi-parental basis) can be used for both true F1 identification in fertile x fertile (FxF) crosses, as well as for subsequent trait MAS in segregating populations that are segregating for the trait of interest. This enables mainstream breeding workflow. Table 2 provides an example list of markers that can be used for MAS and FxF workflow. These marker sequences were used to develop Taqman assays for use in a high throughput laboratory set up (Table 3). These markers are intended to serve as markers in the "Master Loci," which can be used for parental genotyping in new developmental crosses, with subsequent polymorphic markers identified that can be used to identify respective F1’s in FxF screening and also MAS selection in the resulting segregating generations (typically F1M1).

Table 2. List of markers for MAS and FxF workflow.

Q Allele of Allele of L Positi ID Marker SYG- SERRA DNA Sequence G on N 75-1706 NA AAGGTTTGTAACCAAACTCTGACCTTA GATGTTATGATTGTGTGCACAAGCTCT ACTCTT[C/G]CAGCAAAnGATAGCAAT 1 NQ0257512 2 40.84 C G TTGGATCTCCAACCnTCCAACTTCTCT CTAATATATATATnAA GCCTTCTCTTCGATTTTTCATTGACGA AGGTGATGATGCTTTGCCGAATGATCC AATGCT[T/C]TTCCATACTAAAAGAAC 2 NQ0345493 2 41.00 C T CTACCAGCCTAGCACTATCAAACGCA AGAGGACTCATGGTTAT GCGGAAGGTCGCGATCCTCGGGGCCG CTGGGGGnATTGGGCAGCCTTTGTCAC 3 NQ0345038 2 41.33 G A TTCTGAT[A/G]AAGCTTAATCCTCTTGT TACCAAGCTAGCTCTTTATGATATTGC TGGTACTCCTGGCGTG TTTCTTGACATTGGACGATGCGATCAA GACTACAAATAGGAGGGTTAATGCCT 4 NQ0345495 2 42.36 -- -- TGGAGAG[T/C]GTTGTCAAACCAAGGT TGGAGAATACCATTACCTATATCAAG GGAGAGCTGGATGAGTTG CTCAAAACCACCACCGGTCGCATTAA GCAATGCTAGAGAAAGTATTCTGTTA GGTGCAAT[t/c]GCTGCCAACTTGCAAG NQ0345022 2 42.53 C T CAATCATTGCTCCCATGGAGTGACCA AAAnCATGAGCTTTAGTC TTCCCAAGAGATTATGTACCGTGGTCC TCTAGCTCTTTTCGGTGTAGGGCTTGA 6 NQ0257948 2 45.63 T C TGATTA[T/C]TTCCCAATGATTAATATA TATTATTAATTAACTCAGACTTTGACT GCACTATAGTGTCAC ATCAAATAACTTGATGGTTTCTGAGGA ATCCCATGATGTCAAATCCGTTTTATT 7 NQ0258383 2 47.42 C A AGCTAA[A/C]GCAAATGACCAGTGCAA TTTAGCCATnTCAAAATGTTGCTGTCC AAGTGCAAGTAACCCT TGAATCAGAAGGTTCTCTTTGTGCAAT TTGTATCCCTGGCATACTATAATATAC 8 NQ0257610 2 47.47 GAAATG[A/T]AATCATCTCTTATAACC TGGTAGGACATAGGTAGAAAATCTAA CTGGATGATTAGCCAAT GCTTGAAAACATAGTTAAGCAACTTTT TCCTCAAGCTGGTTGTCAATCTTGGTC 9 NQ0258102 2 48.51 ACCTAG[A/G]ATGGTACAGCCGATTTG GAAAACAnTATGGGAAACTAAAAnTG -- -- CACAATTGAGAGAAGGT TTCCATTGCTTCTCTGCCTTTGATCTCC TTCCATTTCTTCAGCCCTACTTTGTCAC GATT[C/G]TCAAAGCTAGGGTTAGTTT NQ0257924 2 48.51 TACTTTTGAATTCGATTTTGAATTCTT AATTCTTATGATTT TCTGGATTGAAAnTTAATGGCAGCAAG GTTGAGAAAGCTGAAGAGAAGGTGGA 2 49.32 AAAGATG[t/c]CTGCTTTGACGCTGAAA 11 NQ0257757 CCAGAGAAGGTTAAAGATGCATCGAA GGCTGAGGCTGTTGTCA AATGACAGTAAAATGGAAAATTGTTC AGGTTTGAGCCTGCGGCATCATGCCCT 12 NQ0258031 2 49.79 CCAAATA[T/C]GGAGTCCATTTTAACA ATCCTTATTTAGAATTACTTTGGTAAA nnAAGCAGAGAGATTAA TTTGGAATTTATAATAGGTAGTGAAA AGAAATGTCTGAATTCAGAGCTCTGG 13 NQ0257938 2 50.08 CATGCATG[T/C]GCTGGACCTCTTGTAT GTTTGCCAACAATCGGGACTCGAGTA GTTTACTTCCCTCAAGGC TTCATGCAnGCATAnATTGATGTATGT TGTATGTAAACAATAACAGTAAGTTTT GTGTTG[T/C]TATTGTAGGTGGAGGGA 14 NQ0258282 2 50.08 GAATGCGAAAGAAGCnGTTGAAGAAC TGGGAGTTGCTTTGAAA CAATCCCACCTACACACACATTTCCAC ACGTTGCATTTTGTGAGTTTATATACT 2 50.53 TTCTGT[T/C]GTTATCTTCATAGTCAAC NQ0258343 CTTGCTTATTTnAACAATAATATAAAA GTGCTTTTGGTAAAA TCTTTCGAATGTGTATTCTGAAGTGAA CAGATGGGATGATGCAGAGACGACGA 16 NQ0258609 2 51.49 GGATTAG[T/C]ATGAAGAATTGTAATG TAGATAAATTGCCTGGATGGAGTTGT -- -- ATAGAGGTTAATGGAAAG CAAAnCATAGCCAACCTCTGCCAGTAA GTTCAACTACCCTCCAAGCACTACCTT 17 NQ0257954 2 51.64 TCACCT[a/g]CACTACAGCTACTTCACC TTCTTCTACCTTCTGCCCGCAAATnCC ATCACTACnCCAACC GGCTTATGACCAGGCAGCTTTTGCCAT GAGGGGGTCGCTGGCAATTTTGAACT 18 NQ0257684 2 52.02 TCTCAGT[C/G]GAAACAGTTGTTGAAT CTTTGAGAGAAGTCAAGTGCCTAAAA GCTGGAGGAGAGTCCCCT GCTTCAGAAAnCCTTAAGTTTTATTTC TTCTGCATCATCACCCCCTCTTCCCTA 19 NQ0258062 2 52.07 TAGTTC[C/G]GATTACTATATTCCCGCC GTACAATTTCCGAAAnCACCTCCAAAT CTTACCGTTTCTCAA GGCTTATGACCAGGCAGCTTTTGCCAT GAGGGGnTCGCTGGCAATTTTGAACTT NQ0258384 2 52.07 CTCAGT[C/G]GAAACAGTTGTTGAATC TTTGAGAGAAGTCAAGTGCCTAAAAG CTGGAGGAGAGTCCCCT 21 NQ0257410 2 53.32 G C AGAAAnGAAGAAGAAAAACAATCGAA TCCCCTACCTCTTATCAGAACATCGAC CCGAACC[C/G]CACAAACCACCCAATA TTCCATTGCCTCATCAAAAATTGCCTC GCCGCCTTCACCCAGAA AATTAAAAnTAAATGGATCACAGACA TTAGTATGAAAGCAAGCAATATATAA 22 NQ0257277 2 53.48 TTAGAATT[T/C]AGGGCTGTTTTGCTAG AAATTTGAGTTTTGCATCTTGCATTTT CAATATGCATGTTAAAA CCTAACCATGGnATTTGTCCAGCTAAG ATCCCCTTCAAGAGCAAGATTCTCAAT 23 NQ0257326 2 55.14 ATTTAG[T/C]ATTAGCGGTTTCCCAAA CTACACTCAAGATCAGGGCAGGCCCT GTATACTGGGTTGCTCT TTAATAAACTGAAAAGGAGGATTCAT TCATTCATGTTAAAGTGCATAAAATAA TAGATGA[T/C]GATGACGATGATGATT 24 NQ0257570 2 55.59 TGGTTTTCGATTTTCTTACCCTTGCAA AAGCTCGAGAAGCTGTG AAAnGAGAAGAGAAAAAAnCATGCCC CTTATCTTGCTATTTATCTCATTTAATC NQ0257962 2 57.17 TCTTAA[T/C]TACTGCATCCGCATCTGA TGCAGAGGAATCCCTTCTTAACTGGA GATCGTCTCTTATAAA ATTTCGTTCTAAGGATGGGGAGTGGC ACTGTTATGTGGATAATGCTGTCTGGT 26 NQ0257220 2 58.38 ACTATGC[t/c]ATGTTATTAGTTGGTGA CAGTTATATTATCATACACTACAAAAA TTGCATGGGTTAATTG AATTCCTCGGAGATGGATATTCTTCTC TGTAAATAGCCTCGAGATTAAATGGC 27 NQ0258453 2 62.51 CTAAATC[A/G]AAACCCATTAACATAT GATATCCAACAAACAAAGTAGGACCC ACAGATGGAATTCCTTCA NQ0257461=NACEP GTATTCAAGTTGGCCCACGTTTCCTCA 2 63.08 009407370 ACTTTATATTGATGGGGAGTTTTATGG AGGGTGTGATATTACTGTTGAAGCAT ACCAGAGTGGGGAACTGCAGGAAGCA ATAGAAAAAGCAATGTGTTCTTAATA ATGTCTCAGTTATA[A/G]CCTTCTATGC TCCATTCATGCAAAGTTACACTTATTT ATTAATTATGTTATTATATAATATATA TCTGCAATTTTCATATTTCAGATCTGT GGATGACACTTACCATTTAGTTGCTTC TGGTGTTTATATTTATTCTACAAAGAC CATTTACTGAGTTTTCAAATGCT CATCTTATAAGTAATATACTTTnAACT TTTAAGGATCTTCAAATATTCTCTTAT 29 NQ0257692 2 69.89 AAATTA[a/g]AGGCCCCAAGATTAATCC AAACTGAATTCATAAACAAnTAAAnTA TCTATTTnAGTTTCT AAGCTGTGATTTGTGCACACTGGTGTG CAGGTGCACTGTGGATAGTAGCAGTT NQ0258523 3 37.78 GTTTnAT[t/c]GGGTGATGGCTAGTTTGG ACTGTGGTCATTAATGTTTAGAGGCTA AAGCAGCTGGTTGAA AAATTAnTTACTGTAAATTCATCAAAC CCTAAnTCAATCATGCAAGTGTGCAAT 31 NQ0258354 3 43.03 TACACC[A/G]CTCAAGTCCCACCATCA TACAATACTTATCGATTTnGATGACTT TCAAAGTTTAGTGCTA TTTGAAGCGGAAAGATATGTCTGTTGT GGTGTCAATGCGCATAATAAAGAAAG 32 NQ0257455 3 45.08 CATCAAA[t/g]GGGTAACTACTATTTCA AAATTCATGTATTCAATCATATTGTTT ATGGGCTTTCGTCGTG TTACTATTAATATCATCCATnTAAACT GTTACGTCATTTCGAAATTTTCATCTC ACTAAA[a/c]GGTGCAAATTGATATGAT 33 NQ0257354 3 50.20 CCATCGAAAATATTTATTTAACCATCn ATTTCAAACGTAGTT TTGTCCTAACCCCTAnATCATATAGTA 3 58.45 34 NQ0344514 -- -- TCTGTGCTCCAATGCCATATTCTCGTG AATCAA[T/C]AGGTAACCCCAAATCTT CGTTGGCTTCCACAGTGTCACGGCCAG CATCTTGCAGATTATA CACTAAAGGATCTGAGCAAACAGCTG TAGAAGTTAATGATAGTGAAAGTGAT NQ0258512 3 60.87 TTGAACCG[a/g]ACAATTTTCATAAACA ATATTCCATTTGATGCTGACAGTGAAG -- -- AGGTGAAAAAGAGATTC TGCAGATCCAAGTAAnTATGGTATTTT TAAATTGATAGCTATCGATTATTTTGG ACCTTT[t/c]CTCTTTTCTGCATTTGATG 36 NQ0345206 3 62.16 ATTGCAAATGTGTTCTGATATTATTAT TTTTCATATTTTTA TTTGATGCGCCTAGGACCCCAACTTAA AGAAAGCCACTTTGAACGTGAGAATG 17.04 4 ATTCTGC[a/g]TATAGTTCATCATTTAG 37 NQ0258361 CATCCCCnTTCACAAATAATGCAAAAC -- -- TTCATTCTCAGATTGC CGCTTGGCATCAGTACAGTAGTTGTAA ATCATGAACTTCCTCTGCACCCACCTC 38 NQ0345564 4 21.73 ATTCTC[t/c]TGTAACTCACCGAATCCA ACTCGTGGTTATACCAATCTGCTGGCG AAGCCGTTGACAACA AnTTAAGGGAGTTTGTGTAAATATCAA CAAGGATACGTAGTCCATCACTACTGT 39 NQ0257741 4 25.93 CATGGn[a/g]GTTAGACGCTCCGGCTTT GGTCAGTGAAGTTACAGGTTGAATCA TGGTAGTGTCATTCAA ATAAATTGGGATCAGCCAGAAAATGC TGAAACACACCTATCAACAATTTATAC 4 30.38 CAGAATC[a/g]CTATTTACAGCCAACAT 40 NQ0258022 GCTAGAGGCACTTCAATAAAATGTTT AGACAGATCAGTCATTT AAGAATTCACTTGTTGATAGCTTCATT 41 NQ0257641 4 30.56 GTCTTGCTGGTTTTCAACTAATCTCAT ATTCTA[A/G]GTTGCCCTGAAATTAAA TGTAAATGGGAAAAATGTGAAAAGGC AGGTTAGAATCTTATAC CTCAATAGGCTTTCTTGGTGAGGCAGA GTAATCGGCATGTCTTCTTGGTGAAGC 42 NQ0345175 4 32.83 AGAGTG[A/G]TCAGTTTGCCTTCTTGG TGCAGGAGAGTACGACCTTGATGTAT GGCGAGCTCTTGAAGAT TAGGTAAAAnTTAAAGAGAAAAGCAT CGTAAATAATTAAGTCACAAAGCAGC 43 NQ0257421 4 35.05 AGGTGTGT[a/c]GAGTCTACACTAAACC AATCCTTTAAGAAGTGTACCACTTATA TACGATTAAATGTATTA CCTAATTTTTCTCCTCAAATATCCCAT TTGTTTCTAACTAAATCTCAAAGGAAA 44 NQ0257536 4 35.60 AGCTTT[T/C]ATTGCACGATAACGGTT AATTTAATCATTCTTCAAGCTACACAA TCAGTCAATCAGTCGT AATTTCGCGATGCATTTGAGATTGTTG TGGAAAnTATGGTGCGTATGGTCACCA 45 NQ0258247 4 37.98 AATGAG[A/G]TATACACGATTCCTTTG TAACGATAAATGTTTGGATGACATTCA ATTGTAGAACCACTGA AATCTTCCAAATGGTCTAAGTTATACA ACCTTAAAGAGCAGCCATATGATTCA TGTATAT[t/c]GACTGAGATAAAATGGA 46 NQ0257556 4 40.61 AAGGTGCAAGTGGTGGTGGAAATTAT AAACATTGCAACCnTCA TTCTATTATTAATAAAAAGAATACTAT TATCCTTAAATCAACAATCTTGGAATC 47 NQ0257799 4 44.79 CTTTAG[T/C]GAGGCAAAGTTACCGAG TTTCGTTTCTCTTGAACTTGTTACAAT AATTACAAAACCATAC CATTTTTAAATATTGGTAATATGCAAA CATATTTTAAGAAAATGCCAAGTAGA 48 NQ0344630 4 45.78 TGAGCCA[t/c]AGAAGATACATTCAATG TCTCCAATGTAGATTTATTTATTTTTTT TAAAACAAGAGAATA ATGTGTTGTTAGATCTGCTTTCTAATT CTCAGGATCGAAAGTCCAATTTCTTGC 49 NQ0344978 4 46.32 TACCTT[a/t]TAAAAGAGCTACCAACGA CAGCATTCAAGCTGTTAATGAAGAAG -- -- ATGACACATCACGTCC GTCTCTGTATAACCAGCCTGGTGCCGC TGGAGCTCCTGGTGGGGCTGACTCAG 50 NQ0345680 4 49.45 CTGGACC[T/G]GTGCCTGGTTCGGAAC CTTCTGGAACTTCGGGTGGTAAGGGG CTGAAGATGGTGATGTTA AGGAGTTTTGGGCGACGGGAGTGAGA TTGCCGTGAAGAAAGTACTGGAATCA 51 NQ0345468 4 50.90 GATCTCCA[T/C]GATGATGAATTCAAG AATGAGGTTGAGATAATCAGCAAGTT -- -- AAGGCATAGAAATCTTGTT AGCCACAACAATAGACCAAAATGnAT TTGCTTCTTTTGCATGACAATATAAAG ATGATGC[A/T]TGCTTCTTCAACCAGG 52 NQ0345333 4 52.02 CAGCACAAGGATGACCTGTTCCATCG AAGTTATTTTTACCACTT TTCATTCAGGTATTTATCATCTCTGTG GAGTGCTAGCGCATGACCGATAAAGT 4 53.59 CAATTGT[A/G]TTGTCATCCAATCCAT 53 NQ0344496 ATTTTGATATGAGCTCTTTAGTAGTCA CCCTTGTAAGGTCCAAT CCTCTGAAATTAAGATACTTTCTGGAG TAGAAACAAGTGAAGCTGCTACTGTT 54 NQ0344746 4 54.31 TCAGGTA[T/C]TGGCAGCGATTCTTCTT CGTCAGAACTATTACCTTCGGATTCTT CTTCTATTGGGTTTTC GAAAAAGACGACGAATCTGCATTTTC GTCCTGAAAGTTAACGATCGCCAGCC 55 NQ0344766 4 56.31 GCCTATCA[T/C]CCTCAGCTTCTTCGAC GTCGCCAAGGGAAGGTGAAGAATCGA ACTCGACGTCGGAGTCTG TATTGGTAAAAnTAAGTACAAAATATA AGAAGATTAAGTTTAATAATCCTGGTT CCTTTA[a/t]ATTGTCCAGACTCTCCCAA 56 NQ0258314 4 61.48 GCAAAACAAGTGAGAAATTAGCATTG GCTTCAAAGTTCAAA GATTAGATTTCGAGAATGGAGAAAAn GGGAGTGTTGGAAGAAACAGTAAAAn 4 67.55 GGAATAAG[t/c]GTAGGTGACCGTTGGA 57 NQ0257998 GATTTTnGTTTATAAAATGCTGATTTA CGATTAAGCTTTAGCCA TGGTATACAAATACAGCTCGATATTG GTTACTAATTGCTTGATATTGGTATGG 58 NQ0257822 4 71.66 TAATACC[a/g]TAATAGCCCTAACTAGC TCTAGGTCTAAAATTTATCTTTTCATG GAAAATGACATAGTTT AGATTGTGTGTTTCCTAGGATTCCTCA GTTAGCAGTTATTGGTTTTTCGGGTAG 59 NQ0345700 4 76.67 TCTTGC[t/g]AATCTTTACACGTTTGAG ATAAGGTCAATGTGGGTGGCTCATTTT CTTGATGGAGGGTTT GCCCTGCTCCAGAGCTTATTCTCACGA CTGGACGGAGTGCCCTTTCGTGCATCC 60 NQ0258259 4 81.48 AGGCGA[A/G]AACGCGCGTCGAAGAG ACTTGAAAAnGTnCGTCTACAGCTGCG TTCCGTGTCCTGAGTTC TATTAAAGTTTnGTCCAAAAGAAGGCG ATAGTGGATCAACTGAATATCCAACA 61 NQ0344778 4 83.34 AGTCCAT[a/g]GTTATTGTTGTTATTAC GATAATTGGATGGAGAGCTTCCACCT GGACTGCCAATTAAAGA TGCCTTCCAGCATAAACACCCCTGCAC AAAATGCTACATTTGTTAGGACGTGTC 62 NQ0344946 4 88.52 TTGCTA[t/c]TGAGCAAAAATACCCAAA TTGGTTGACTCAGTTGCCTCCAAATGA TAATAATAATAAAAC 63 NQ0257917 4 92.84 C T AACTGTAGTACAGAAATAAACTAGTC TGAACCCATGCTTCGCACATGGAATC GCACAACA[t/c]GATTAAATAAAATTTG CATAGTACATTTCAGGTTTGCGATGTT TGACAAATACATCAGAT CTATAGTGCAGAGCTTGAACTTGAAC CAAAGCAGTATCATGTAATTGCATTTG 64 NQ0257378 6 4.61 AA[a/g]nTCCAGCAGATTCTAAAAnTTT CTGTTATATTGTGCAAGCACATATGGA GATGTTAGGAA TCAGGTTGGAGCGGACCCGGAAAGTG CAGCCGCCTACAATGGAGGTTTGGTT 65 NQ0344375 6 8.04 AGGAAGTT[t/c]AATGGTGGAGGAGGG ACGCCGTTGATGCCGAAGAGGAAGTT TGAGACGTACATTTTTGCG CAATGAGACATAGCCAATTGGCATTT CGCAGCACTGACCTAAAATGGATTCA TAATCAAA[t/c]CCTTCTAAAGGCAAAC 66 NQ0344545 6 13.68 CATTCAAACTTCTATTAGTGATTCTCT TTACGGCCTCACGTCGA ACAATTGCTATCTTCGTTTTTACATnAC CGTTTGGTGGTCGATAACATAGATGA 67 NQ0345400 6 17.69 ATGAAA[t/c]GAGGAGGATTTGATGAA GCAGCAGCAACACCTAAATATGAACC CATCTTCAATTCCGTGC TGTGGATTAGCTACTAAAAATTATACA TGATTTCAGGAAATGAAGCACATTATT CAATCATAAAGCAAGCTCAGCTGGTT CACCTGGAT[TAGGCCTGTCAAAATTC ACTAAACCCATTTAACCCTACCCTCTT AACCTTATTTTAGACAGGCCGGGCCTT 68 NACEP009089369 6 22.28 CTCTGAATTCTTTCCTTCGCAACCCGT TTAACCTCTTACTCTTCATACGACCCG TTTAACGTTGTTGC/GACTTGTGTGAA GCACACATTCTGCTGCTGAACCATCCT AAAGCGGAAGGGCGATACATATGCTC TTCTCATGACGTGACAATTTACGATAT -- -- GGCTAAAATGATTAGGCAGAACTACC CTCAATATTACATTCCTCAAC]GACTC AGATATAACTACTTTTGGATTATGGGC TTATGATGCTGCTTTTGCCTTAGCAAT 69 NQ0258009 6 22.44 GGCTAC[T/C]GAGTCAGCTCAGCCAGC TTATAACTATAGTAATGAnGTTGCTAA CGGTAATTTAATGAAG AGAAATTACAGTTGATAAAGTAGCCG ATGAAGGCAATCTTACACTAGCACAA 70 NQ0344415 6 22.44 AGTTTTAG[T/C]GATAACCACAGTGAT AGGGATTCAAGAAAAnCACTGGCTCA CTTAACAATGAGCAAATCT GCATTCCATAACCACCATTCAACATGC ACTCCACTGGCATGCAATATGTTATTA NATTTTATGATCAAG[C/T]ACTTTCATC 6 22.65 71 NACEP009090969 AGCTGTTACAAGTTGTGACTGTTCGCT GCTAATAACTTAATAATTCTGTCACTA -- -- CAACAAAT TGGTGTTTCTGGAGCTGAAGCATTTGG AGAAGTATTCACATTGAAGGAAnTAG 72 NQ0344386 6 26.52 GCATTTG[A/C]ACAGTGCCATAGCAAT TTGGCTCAGAACCAGnCGCACAGATC -- -- AAAGGATTTCCTACAATG TGACTCTATACTAGATGATGAGTTCTC CTTCTCCAACCTCAACTTATCACATCT GCTATT[t/c]TGACTAACATTCATTGCAT 73 NQ0345529 6 31.49 CACTTCTGCTTCTTTGAACTCTTTGTTG -- -- CAATCCAACATTC ATGGCTTGAAnGGTCGCTCATCAnCCC CCAGCGGTCCGACCACTCTATATCCAA 74 NQ0345734 6 33.62 TCTCCT[c/g]CGCCTCGATTATCTTCTCC TCTTTACTCTTCCCACTCACTTTAAACT -- -- TCCTCACGGATCC Table 3. List of markers for Taqman assays.

L Positi Tra Probe VIC Probe FAM Primer F Primer R Marker G on it Sequence Sequence Sequence Sequence TTTGTAACCAA GGTTGGAGAT AGCTCTACTC CTCTACTCTTGC ACTCTGACCTT CCAAATTGCT TTCCAGCAAA FB AGCAAA (SEQ ID AGATGTT (SEQ ATC (SEQ ID (SEQ ID NO:75) NQ0257512 2 40.8 R NO:116) ID NO:157) NO:198) GACGAAGGTG GCTAGGCTGG ATGATCCAAT TGATCCAATGCT ATGATGCTTTG TAGGTTCTTT GCTTTTCCAT FB CTTCCAT (SEQ C (SEQ ID TAGT (SEQ ID (SEQ ID NO:76) NQ0345493 2 41 R ID NO:117) NO:158) NO:199) GAGCTAGCTT TCACTTCTGA ACTTCTGATGA CGGAAGGTCG GGTAACAAG TAAAGCTT FB AGCTT (SEQ ID CGATCCTC AGGATT (SEQ (SEQ ID NO:77) NQ0345038 2 41.3 R NO:118) (SEQ ID NO:159) ID NO:200) GGACGATGCG GGTAATGGTA CCTTGGAGAG TTGGAGAGCGT ATCAAGACTA TTCTCCAACC TGTTGTC (SEQ FB TGTC (SEQ ID CAAAT (SEQ ID TTGGT (SEQ ID NO:78) NQ0345495 2 42.4 R NO:119) NO:160) ID NO:201) GTCCTCTAGCT CACTATAGTG ATCATTGGGA CATTGGGAAGT CTTTTCGGTGT CAGTCAAAGT AATAATCAT FB AATCAT (SEQ ID AG (SEQ ID CTGAGT (SEQ (SEQ ID NO:79) NQ0257948 2 45.6 R NO:120) NO:161) ID NO:202) GAATCCCATG GCACTTGGAC CTGGTCATTT TGGTCATTTGCG ATGTCAAATCC AGCAACATTT GCTTTAGCT FB TTAGCT (SEQ ID GTTT (SEQ ID TGA (SEQ ID (SEQ ID NO:80) NQ0258383 2 47.4 R NO:121) NO:162) NO:203) TTAGATTTTC ATACGAAATG TGTGCAATTTG TACCTATGTC AAATCATC ATACGAAATGT TATCCCTGGCA CTACCAGGTT FB (SEQ ID NO:81) AATCATC (SEQ TA (SEQ ID (SEQ ID NQ0257610 2 47.5 R ID NO:122) NO:163) NO:204) CTTTTTCCTCA ACCTTCTCTC TTGGTCACCT TGGTCACCTAG AGCTGGTTGTC AATTGTGCA AGAATGGTA GATGGTA (SEQ AAT (SEQ ID (SEQ ID (SEQ ID NO:82) NQ0258102 2 48.5 R ID NO:123) NO:164) NO:205) AAATCATAA GAATTAAGA CTAGCTTTGA TCCATTTCTTC ATTCAAAATC GAATCGT CTAGCTTTGACA AGCCCTACTTT GAATTCAAA (SEQ ID NO:83) FB ATCGT (SEQ ID GTC (SEQ ID AG (SEQ ID NQ0257924 2 48.5 R NO:124) NO:165) NO:206) TTTACCAAAG ATGGACTCCA TAATTCTAAA TATTTG (SEQ ATGGACTCCGT GAGCCTGCGG TAAGGATTGT FB ID NO:84) ATTTG (SEQ ID CATCATG (SEQ T (SEQ ID NQ0258031 2 49.8 R NO:125) ID NO:166) NO:207) AGAAATGTCT GAGTCCCGAT TCCAGCACAT CAGCGCATGCA GAATTCAGAG TGTTGGCAAA GCATG (SEQ FB TG (SEQ ID CTCTGG (SEQ C (SEQ ID ID NO:85) NQ0257938 2 50.1 R NO:126) ID NO:167) NO:208) ATTGATGTATG CCACCTACAA TTGTATGTAAA CAAAGCAAC TAACAACAC CACCTACAATA CAATAACAGT TCCCAGTTCT FB (SEQ ID NO:86) GCAACAC (SEQ AAGT (SEQ ID TCAAC (SEQ NQ0258282 2 50.1 R ID NO:127) NO:168) ID NO:209) TTTTACCAAA ACTTTCTGTT ACATTTCCACA AGCACTTTTA GTTATCTTC TTCTGTCGTTAT CGTTGCATTTT TATTATTGTT FB (SEQ ID NO:87) CTTC (SEQ ID GT (SEQ ID (SEQ ID NQ0258343 2 50.5 R NO:128) NO:169) NO:210) GAACAGATGG CTCTATACAA ACAATTCTTC AATTCTTCATGC GATGATGCAG CTCCATCCAG ATACTAATCC FB TAATCC (SEQ ID AGA (SEQ ID GCAAT (SEQ (SEQ ID NO:88) NQ0258609 2 51.5 R NO:129) NO:170) ID NO:211) CTTCTCAGTC TTCTCAGTGGA GGGTCGCTGG GCTTTTAGGC FB GAAACAG AACAG (SEQ ID CAATTTTGAA ACTTGACTTC NQ0257684 2 52 R (SEQ ID NO:89) NO:130) (SEQ ID NO:171) TCTCA (SEQ ID NO:212) CGGAAATTGT CCCTATAGTT CCTATAGTTCGG CTGCATCATCA ACGGCGGGA CCGATTACT FB ATTACT (SEQ ID CCCCCTCTT ATAT (SEQ ID (SEQ ID NO:90) NQ0258062 2 52.1 R NO:131) (SEQ ID NO:172) NO:213) GCTTTTAGGC CTTCTCAGTC TTCTCAGTGGA CTTATGACCAG ACTTGACTTC GAAACAG FB AACAG (SEQ ID GCAGCTTTTGC TCTCA (SEQ (SEQ ID NO:91) NQ0258384 2 52.1 R NO:132) (SEQ ID NO:173) ID NO:214) CCCCTACCTCT GGCAATTTTT CCGAACCCCA CGAACCGCACA TATCAGAACA GATGAGGCA CAAAC (SEQ FB AAC (SEQ ID TCGA (SEQ ID ATGGAA (SEQ ID NO:92) NQ0257410 2 53.3 R NO:133) NO:174) ID NO:215) GCAAGATGC ACAGCCCTAA TCACAGACATT AAAACTCAA ATTCTA (SEQ AGCCCTGAATT AGTATGAAAG ATTTCTAGCA FB ID NO:93) CTA (SEQ ID CAAGCA (SEQ (SEQ ID NQ0257277 2 53.5 R NO:134) ID NO:175) NO:216) CCCCTTCAAGA GCCCTGATCT ACCGCTAATA CGCTAATGCTA GCAAGATTCTC TGAGTGTAGT CTAAATAT AATAT (SEQ ID A (SEQ ID TTGG (SEQ ID (SEQ ID NO:94) NQ0257326 2 55.1 PR NO:135) NO:176) NO:217) GCAAGGGTA CATCGTCATC GAGGATTCATT AGAAAATCG ATCATCT (SEQ CATCGTCATCGT CATTCATGTTA AAAACCA ID NO:95) CATCT (SEQ ID AAGTGCAT (SEQ ID NQ0257570 2 55.6 PR NO:136) (SEQ ID NO:177) NO:218) CATGCCCCTTA CAGTTAAGA CGGATGCAGT CGGATGCAGTA TCTTGCTATTT AGGGATTCCT AATTAAGA GTTAAGA (SEQ ATCTCA (SEQ CTGCAT (SEQ (SEQ ID NO:96) NQ0257962 2 57.2 PR ID NO:137) ID NO:178) ID NO:219) TGTTAATGGG GATATTCTTCT TGGGTCCTAC TTTTGATTTA AATGGGTTTCG CTGTAAATAG TTTGTTTGTT Col G (SEQ ID ATTTAG (SEQ ID CCTCGAGATT GGAT (SEQ ID NQ0258453 2 62.5 or NO:97) NO:138) (SEQ ID NO:179) NO:220) AACATAATTA AGCATAGAAG CTGCAGGAAG ATAAATAAGT NACEP0094 GTTATAACTG CATAGAAGGCT CAATAGAAAA GTAACTTTGC 07370/NQ02 Col (SEQ ID NO:98) ATAACTG (SEQ AGCAA (SEQ ID ATGAA (SEQ 57461 2 63.1 or ID NO:139) NO:180) ID NO:221) GCTTCATTGTC CCTGCCTTTT ATTTCAGGGC TCAGGGCAACC TTGCTGGTTTT CACATTTTTC AACTTAGAAT PN TAGAAT (SEQ ID CAA (SEQ ID CCATT (SEQ (SEQ ID NO:99) NQ0257641 4 30.6 BR NO:140) NO:181) ID NO:222) TGAAGCAGAG GCAGAGTAAT GTCGTACTCT TGATCAGTT AAGCAGAGTGG CGGCATGTCTT CCTGCACCAA PN (SEQ ID TCAGTT (SEQ ID CTT (SEQ ID (SEQ ID NQ0345175 4 32.8 BR NO:100) NO:141) NO:182) NO:223) CCCATTTGTTT TGATTGACTG TCGTGCAATA CTAACTAAATC ATTGTGTAGC AAAGC (SEQ TCGTGCAATGA TCAAAGGAAA TTGAAGA PN ID NO:101) AAGC (SEQ ID A (SEQ ID (SEQ ID NQ0257536 4 35.6 BR NO:142) NO:183) NO:224) GTCATCCAAA CACCAAATGA CGATGCATTTG CATTTATCGT GATATACAC CACCAAATGAG AGATTGTTGTG TACAAAGGA (SEQ ID PN GTATACAC (SEQ GAA (SEQ ID A (SEQ ID NO:102) NQ0258247 4 38 BR ID NO:143) NO:184) NO:225) TAAAAAGAAT AGTTCAAGA CTTTGCCTCA ACTATTATCCT GAAACGAAA CTAAAGG TTTGCCTCGCTA TAAATCAACA CTCGGTAA (SEQ ID PN AAGG (SEQ ID ATCT (SEQ ID (SEQ ID NO:103) NQ0257799 4 44.8 BR NO:144) NO:185) NO:226) CACCCGAAGT CAGGCACAGG AGGCACCGGTC CGCTGGAGCT TCCAGAAGGT TCCAG (SEQ CAG (SEQ ID CCTGGTG (SEQ T (SEQ ID ID NO:104) NQ0345680 4 49.4 or NO:145) ID NO:186) NO:227) TCAGATCTCC ATTGCCGTGA GCCTTAACTT ATGATGATG AGATCTCCACG AGAAAGTACT GCTGATTATC Col (SEQ ID ATGATG (SEQ ID GGAA (SEQ ID TCAACCT NQ0345468 4 50.9 or NO:105) NO:146) NO:187) (SEQ ID NO:228) AGCCACAACA CCTTGTGCTG AAGATGATGC AAAGATGATGC ATAGACCAAA CCTGGTTGA ATGCTTC (SEQ Col TTGCTTC (SEQ ATG (SEQ ID (SEQ ID ID NO:106) NQ0345333 4 52 or ID NO:147) NO:188) NO:229) TCGCTGCCAA GGAGTAGAAA TCCGAAGGTA TACCTGA CGCTGCCAGTA CAAGTGAAGC ATAGTTCTGA Col (SEQ ID CCTGA (SEQ ID TGCTA (SEQ ID CGAAGA (SEQ NQ0344746 4 54.3 or NO:107) NO:148) NO:189) ID NO:230) CTTTTTGAAC CAAGAAATGA AGGAAGTTGA CATTTCTTTT GCAGTAATAT AAGAAATGAGC AAAGGCCATT CTCCTGTCT (SEQ ID GGTAATAT (SEQ AACGA (SEQ ID (SEQ ID NO:108) NQ0345071 5 7.1 BR ID NO:149) NO:190) NO:231) CGAGTGCTCCC CCTACCAAAA CCGCCATAGC CGCCATGGCTCT TCATGTATTTG CGCCAAAGA TCTAA (SEQ PN AA (SEQ ID G (SEQ ID ATTACA (SEQ ID NO:109) NQ0345144 5 11 BR NO:150) NO:191) ID NO:232) TCTTGAATCT TGAAAGTGTG CCTTGAGTACC CTCTGTTAAT TCATCAATTA AAAGTGTGTCG TAGGTGACTAT AGTTCAAATC (SEQ ID PN TCAATTA (SEQ CGT (SEQ ID GTG (SEQ ID NO:110) NQ0258331 5 19 BR ID NO:151) NO:192) NO:233) AAGAGTAAGA GGTTAAACGG GTTGC (SEQ ID CCTGGATTAG R NO:193), AATTATACAT GCCTG (SEQ locu ATCATTTTAGC GATTTCAGGA ID NO:111) s; CCTGGATGACTT CATATCGTAA AATGAAGCA NACEP0090 colo GTGT (SEQ ID ATTGTCA (SEQ C (SEQ ID 89369 6 22.3 r NO:152) ID NO:239US) NO:234) TCATTACTAT CAATGGCTAC GCTTATGATGC AGTTATAAGC TGAGTCAG R AATGGCTACCG TGCTTTTGCCT TGGCTGAG (SEQ ID locu AGTCAG (SEQ ID TAG (SEQ ID (SEQ ID NO:112) NQ0258009 6 22.4 s NO:153) NO:194) NO:235) ACTGTGGTTA CGATGAAGGC GCTCATTGTT R TCACTAAAA CTGTGGTTATCG AATCTTACACT AAGTGAGCC locu (SEQ ID CTAAAA (SEQ ID AGCA (SEQ ID AGTG (SEQ ID NQ0344415 6 22.4 s NO:113) NO:154) NO:195) NO:236) CTGATGAAAG locu ACTCCACTGGC AGCGAACAG TGCTTGATC s; CTGATGAAAGT ATGCAATATGT TCACAACTTG (SEQ ID NACEP0090 colo ACTTGATC (SEQ TAT (SEQ ID TAACA (SEQ NO:114) 90969 6 22.6 r ID NO:155) NO:196) ID NO:237) AGTAGAAATA AGTGAAGAAT ATTGATGTG GAGTTACCTC (SEQ ID TTAGCT (SEQ NO:197), AN ID NO:115) TACAATATGAT TGGTTTGAGC S TTGGAGCATAC ACAGAAAATC TTGTTGGTTT NACEP0091 colo CCTA (SEQ ID AGAG (SEQ ID GGAG (SEQ ID 12570 -- -- r NO:156) NO:240US) NO:238) Example 5 Onion Fusarium Basal Rot (FBR) LG2 QTL Fine mapping F3 bulbs were obtained from the original SYG1706/Serrana-FBR mapping population described in Example 1. Segregating F2:3 families were chosen based on desired genotype data in the QTL region for FBR on LG2, on order to narrow the major effect FBR QTL region from >12 cM to less than 5 cM. The F2 genotype in the LG2 QTL region of the selected F3 families is depicted in Table 4. As seen in Table 4, the F2:3 segpop families were chosen to have a recombination in the FBR QTL LG2 region, and heterozygous (shaded) for a "stair-stepped" section of the QTL region in the F2 generation. The heterozygous region in the F2 individuals was chosen such that F3 individuals (bulbs) homozygous for the favorable allele and homozygous for the unfavorable allele could be selected for further experimentation in the F3 generation to enable fine mapping.

NQ0257461 NQ0258453 NQ0257570 NQ0257326 NQ0257277 NQ0257410 NQ0258384 NQ0257684 NQ0257954 NQ0258609 NQ0258031 NQ0257848 NQ0258005 NQ0258383 NQ0257948 NQ0257827 NQ0345038 Table 4. Genotype depiction of the six F2 plants selected for FBR LG2 QTL fine mapping. F3 bulbs from each of these families were genotyped with markers in the LG2 QTL region as subsequently described.

LG 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 41.3 42.4 45.6 47.4 49.2 49.8 49.8 51.5 51.6 52 52.1 53.3 53.5 55.1 55.6 62.5 63.1 Pedigree Source FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR PRR PRR color color SYG1706 HCH0351-S1 GG CC TT CC GG CC TT CC AA CC CC GG TT CC CC GG GG RV_SYG 1706/SERRANA- HCS0063 AG CT CT AC CG CT CT CT AG CC CC GG TT CC CC GG GG FBR:01.0032.

RV_SYG 1706/SERRANA- HCS0333 AA TT CC AC CG CT CT CT AG CC CC GG TT CC CC GG AG FBR:01.0167.

RV_SYG 1706/SERRANA- HCS0367 AG CT CT -- CG CT CT CT AG CG CG GG TT CC CC GG GG FBR:01.0001.

RV_SYG 1706/SERRANA- HCS0293 AG CT CT AC CG CT CT CT AG CG CG CG CT CC CC GG GG FBR:01.0147.

RV_SYG 1706/SERRANA- HCS0591 AG CT CT AC CG CT CT CC AA CC CC GG TT CC CC GG GG FBR:01.0113.

RV_SYG 1706/SERRANA- HCS0699 AG CT TT CC GG CC TT CC AA CC CC GG TT CC CC GG GG FBR:01.0167.

Based on the genotypes in the LG2 QTL of the F3 bulbs from each of the six families in Table 4, bulb selections for the homozygous favorable and unfavorable alleles were made.

For example, for the segregating population RV_SYG1706/SERRANA-FBR:01.0113. cross, ten F3 bulbs that were fixed homozygous for the Serrana allele at and to the left of position 49.8 on LG2 and ten F3 bulbs that were fixed homozygous for the SYG1706 allele across the whole FBR QTL region were selected (see Table 5). The selected bulbs (one separate cage for each allele "group") for each of the 6 segregating populations were transplanted into 16 head cages in a cage field north of Woodland in December. The F3 bulb selections for favorable and unfavorable alleles at each "stair step" are separately massed to produce seed fixed for only the recombinant QTL region of interest, while keeping the rest of the genome heterogeneous (reducing the chance of inbreeding depression and background QTL effects).

The massed seed is harvested and tested for FBR. For each of the 6 families, a statistical difference between the two entries that represent the two massed allele "groups" of that family allows determination of whether the FBR resistance is located with the respective genetic interval for which that F3 family is segregating.

Table 5. Example of F3 bulbs selected for massing (family RV_SYG 1706/SERRANA-FBR:01.0113.).

Chr 2 2 2 2 2 2 2 2 2 2 2 Pos 41 46 47 50 51 52 52 53 53 56 63 Trait QTL: FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR PRR color SYG1706 (HCH0351-S1) F3 plant ID GG TT CC TT CC CC CC GG TT CC GG RV_SYG1706/SERRANA- 353 AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 359 AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 375 AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 395 AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 402 AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 408 AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 413 AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- AA CC AA CC CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 351 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 389 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 390 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 405 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 425 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 440 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 445 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 448 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

NQ0345038 NQ0257948 NQ0258383 NQ0258031 NQ0258609 NQ0257684 NQ0258384 NQ0257410 NQ0257277 NQ0257570 NACEP009407370 RV_SYG1706/SERRANA- 451 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

RV_SYG1706/SERRANA- 496 GG TT CC TT CC CC CC GG TT CC GG FBR:01.0113.

Subsequently, 29 additional F2:3 families have been chosen from the SYG 1706/Serrana population for further fine mapping of the FBR QTL on LG2, as well as validation of the QTLs for FBR on LG3 and LG4.

The F3 families for the FBR QTL fine mapping project represent more coverage of the FBR QTL region on LG2, to produce individuals that allow further narrowing of the FBR QTL region on LG2.

The F3 families for the FBR QTL validation are represented by families that are fixed for the Serrana favorable alleles in the major FBR QTL region on LG2, but are heterozygous for the minor QTL regions on LG3 and LG4. Similar selection for individuals homozygous for various combinations of both alleles for the minor QTL (given that LG2 QTL is fixed), as described above, produce massed seed entries that can be trialed to determine if the minor QTL provide significant additional resistance to FBR.

Example 6 Onion FBR-PR Resistance Trait Coupling Project Similar to the fine mapping project, coupling of FBR and PR resistance could be accomplished through a 2-tier approach using available F3 bulbs, as well as planting F3 seed sources of genetic material from the SYG1706/Serrana population. Bulbs are sampled to identify individuals that combine the favorable alleles for FBR QTL from Serrana on LG2 with the favorable alleles for PR from SYG1706 on LG2, in a North American yellow bulb (or Universal Yellow).

For the steckling/seed source approach, seven F3 families were selected based on F2 plant marker data to have a favorable combination of alleles in the LG2 trait region and LG6 color QTL region, as well as a favorable phenotypic disease score. The F3 seed was planted and resulting F3 plants genotyped with Taqman markers that encompassed the main QTL for FBR on LG2, minor QTL for FBR on LG3 & LG4, PR QTL region on LG2, plus color QTL regions on LG2 and LG6. Recombinant individuals from each F3 family were identified to contain as much of the full complement of traits as possible in either a fixed or heterozygous state, and "like" individuals were placed together in a head cage for future massing.

Table 6 presents representative genotypes of the F2 families that were initially selected for follow-up, and the selections of the resulting F3 plants that were selected to have desirable recombination for combining the traits. Markers to indicate the favorable alleles for FBR resistance (FBRR) on LG2 were used as the main criteria, followed by favorable alleles for PR resistance (PRR) on LG2 and lastly the favorable color alleles, ideally the Universal Yellow, which combines the Serrana color allele on LG2 and the SYG1706 color allele on LG6; however, obtaining a North American yellow was also an objective, which requires a SYG1706 color allele for both LG2 and LG6 color regions/QTL. The massed seed from these cages is harvested and trialed to verify the traits have been coupled. In the cases of Universal Yellow FBR+PR combinations, this involves a double recombination on LG2 and therefore these require one additional generation of MAS to fix all traits.

NQ0344415 NQ0258009 NQ0258453 NQ0257570 NQ0257326 NQ0257277 NQ0257410 NQ0258384 NQ0257684 NQ0258609 NQ0258031 NQ0258383 NQ0257948 NQ0345038 Table 6. Genotypic and phenotypic information for a majority of the F2 families selected for trait coupling in subsequent F3 (and beyond) generations.

FBR score Score LG 2 2 2 2 2 2 2 2 2 2 2 2 6 6 Deforest, Pos 41.3 45.6 47.4 49.8 51.5 52 52.1 53.3 53.5 55.1 55.6 62.5 22.4 22.4 Donna, Desired Haplotype - Universal FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBR-PR PRR PRR COLOR color color TX %mortality Desired Haplotype - NA Yellow: FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBRR FBR-PR PRR PRR COLOR color color Parent: SYG1706 (HCH0351- GG TT CC TT CC CC CC GG TT CC CC GG TT CC PRR 94.8 F2 progenitor plant, AG CT AA CC TT GG GG CC CC CT CT AG TT CC seg 75.8 HCS0103 F3 selections, FBR-PR- Cage 1: AA CC AA CC TT GG GG CC CC CC CC GG TT CC NA Yellow F3 selections, FBR-PR- Cage 2: AA CC AA CC TT GG GG CC CC CC CC AG TT CC seg Univ Yellow F2 progenitor plant, AG CT AC CT CT CG CG CG CT -- CT AA -- CC seg 69.2 HCS0149 F3 selections, FBR- Cage 3: AA CC AA CC TT GG GG CC CC CT CT AA TT CC seg PRR-Univ Yellow F3 selections, seg FBR- Cage 4: AG CT AC CT CT CG CG CG CT CC CC AA TT CC PRR-Univ Yellow F2 progenitor plant, AA CC AA CC CT CG CG GG TT CC CC GG CT CT PRR 73.9 HCS0537 F3 selections, FBR- Cage 5: AA CC AA CC TT GG GG GG TT CC CC GG TT CC PRR-NA Yellow F2 progenitor plant, AG CT AC CT CT CG CG CG CT CT CT AA CC CT seg 70.6 HCS0189 F3 selections, seg FBR- Cage 6: AG CT AC CT CT CG CG CG CT CC CC AA CC CT PRR-seg Univ Yellow F3 selections, FBR- Cage 6: AA CC AA CC TT GG GG CC CC ** CT AA CC CC seg PRR-Univ Yellow F2 progenitor plant, AG CT AC CT CT CG CG CG CT CT CT AA TT CC seg 87.4 HCS0275 F3 selections, FBR- Cage 7: AA CC AA CC TT GG GG CC CC CT CT AA TT CC seg PRR-Univ Yellow F3 selections, seg FBR- Cage 8: AG CT AC CT CT CG CG CG CT CC CC AA TT CC PRR-Univ Yellow F2 progenitor plant, AG CT AC CC TT GG GG CC CC CT CT AG CT CT seg 73.9 HCS0723 F3 selections, FBR Cage 9: GG TT CC CC TT GG GG CC CC TT CC GG TT CC trunc-PRR-NA yellow F3 selections, FBR- Cage 10: AA CC AA CC TT GG GG CC CC TT CT AG CT ** seg PRR-seg color F3 selections, FBR Cage 11: GG TT CC CC TT GG GG CC CC TT CC AG ** CT trunc-PRR-seg color Shown are the F2 genotypes for the QTL regions of interest, and below each F2 progenitor is a representative genotype of the (several) F3 progeny that were selected to mass in cages for creation of a trait donor. The desired haplotype was a North American or Universal Yellow with FBR + PR resistance. Several cages provide a North America yellow FBR + PR donor and several cages provide a Universal Yellow FBR + PR donor (requiring 1 round of additional MAS).

Claims (20)

WHAT IS CLAIMED IS:

1. A method of detecting in at least one onion plant a genotype associated with bulb color, the method comprising detecting in at least one onion plant an allele of at least one polymorphic nucleic acid that is associated with bulb color, wherein the polymorphic nucleic acid is in or genetically linked to an onion genomic region defined by loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6) conferring a red pigment bulb color.

2. The method of claim 1, further comprising selecting at least one onion plant in which a genotype associated with bulb color has been detected.

3. The method of any one of the preceding claims, wherein the onion plant is an agronomically elite line.

4. The method of any one of the preceding claims, wherein the onion plant is a hybrid or an inbred.

5. The method of any one of the preceding claims, wherein the onion plant is a progeny plant resulting from the cross of at least one parent plant comprising disease resistance.

6. A method for producing an onion plant that comprises in its genome at least one locus associated with bulb color, the method comprising: (i) crossing a first onion plant lacking a locus associated with bulb color with a second onion plant comprising a locus associated with bulb color defined by an onion genomic region defined by loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6) conferring a red pigment bulb color; (ii) detecting in progeny resulting from said crossing at least a first polymorphic locus in or genetically linked to said locus associated with bulb color; and (iii) selecting an onion plant comprising said polymorphism and said locus associated with or bulb color.

7. The method of claim 6, further comprising the step of: (iv) crossing the onion plant of step (iii) with itself or another onion plant to produce a further generation.

8. The method of claim 7, wherein steps (iii) and (iv) are repeated from about 3 times to about 10 times.

9. The method of claim 6, wherein the onion plant is an agronomically elite line.

10. The method of claim 6, wherein the onion is a hybrid or an inbred.

11. A method of onion plant breeding, the method comprising the steps of: (i) selecting at least a first onion plant comprising at least one allele of a polymorphic nucleic acid that is in or genetically linked to a QTL associated with bulb color, wherein the QTL maps to an onion genomic region defined by loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6) conferring a red pigment bulb color; and (ii) crossing the first onion plant with itself or a second onion plant to produce progeny onion plants comprising the QTL associated with disease resistance or bulb color.

12. The method of claim 11, wherein at least one polymorphic nucleic acid that is genetically linked to said QTL associated with bulb color maps within 40 cM, 20 cM, 15 cM, 10 cM, 5 cM, or 1 cM of said QTL associated with bulb color.

13. A method of introgressing an allele into an onion plant, the method comprising: (i) genotyping at least one onion plant in a population with respect to at least one polymorphic nucleic acid located in or genetically linked to an onion genomic region defined by loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6) conferring a red pigment bulb color; (ii) selecting from the population at least one onion plant comprising at least one allele associated with bulb color; and (iii) introgressing said allele into a second onion plant.

14. The method of claim 13, wherein the onion plant is an agronomically elite line.

15. The method of claim 13, wherein the onion is a hybrid or an inbred.

16. An onion plant obtained by the method of claim 13.

17. The method of claim 1, wherein said method comprises detecting a marker genetically linked to marker NACEP009089369 (SEQ ID NO:68), marker NQ0258009 (SEQ ID NO:69), marker NQ0344415 (SEQ ID NO:70), or marker NACEP009090969 (SEQ ID NO:71).

18. The method of claim 6, wherein step (ii) comprises detecting a marker genetically linked to marker NACEP009089369 (SEQ ID NO:68), marker NQ0258009 (SEQ ID NO:69), marker NQ0344415 (SEQ ID NO:70), or marker NACEP009090969 (SEQ ID NO:71).

19. The method of claim 11, wherein said selecting comprises detecting a marker genetically linked to marker NACEP009089369 (SEQ ID NO:68), marker NQ0258009 (SEQ ID NO:69), marker NQ0344415 (SEQ ID NO:70), or marker NACEP009090969 (SEQ ID NO:71).

20. The method of claim 13, wherein said selecting comprises detecting a marker genetically linked to marker NACEP009089369 (SEQ ID NO:68), marker NQ0258009 (SEQ ID NO:69), marker NQ0344415 (SEQ ID NO:70), or marker NACEP009090969 (SEQ ID NO:71). SEMB012USP1_ST25 SEQUENCE LISTING <110> Seminis Vegetable Seeds, Inc. <120> Disease Resistance Loci in Onion <130> SEMB:012USP1 <140> Unknown <141> 2013‐11‐27 <160> 240 <170> PatentIn version 3.5 <210> 1 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (69)..(69) <223> n is a, c, g, or t <220> <221> misc_feature <222> (93)..(93) <223> n is a, c, g, or t <220> <221> misc_feature <222> (119)..(119) <223> n is a, c, g, or t <400> 1 aaggtttgta accaaactct gaccttagat gttatgattg tgtgcacaag ctctactctt 60 scagcaaang atagcaattt ggatctccaa ccntccaact tctctctaat atatatatna 120 a 121 <210> 2 <211> 121 <212> DNA <213> Artificial sequence Page 1 SEMB012USP1_ST25 <220> <223> Marker sequence <400> 2 gccttctctt cgatttttca ttgacgaagg tgatgatgct ttgccgaatg atccaatgct 60 yttccatact aaaagaacct accagcctag cactatcaaa cgcaagagga ctcatggtta 120 t 121 <210> 3 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (34)..(34) <223> n is a, c, g, or t <400> 3 gcggaaggtc gcgatcctcg gggccgctgg gggnattggg cagcctttgt cacttctgat 60 raagcttaat cctcttgtta ccaagctagc tctttatgat attgctggta ctcctggcgt 120 g 121 <210> 4 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 4 tttcttgaca ttggacgatg cgatcaagac tacaaatagg agggttaatg ccttggagag 60 ygttgtcaaa ccaaggttgg agaataccat tacctatatc aagggagagc tggatgagtt 120 g 121 <210> 5 <211> 121 <212> DNA Page 2 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (107)..(107) <223> n is a, c, g, or t <400> 5 ctcaaaacca ccaccggtcg cattaagcaa tgctagagaa agtattctgt taggtgcaat 60 ygctgccaac ttgcaagcaa tcattgctcc catggagtga ccaaaancat gagctttagt 120 c 121 <210> 6 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 6 ttcccaagag attatgtacc gtggtcctct agctcttttc ggtgtagggc ttgatgatta 60 yttcccaatg attaatatat attattaatt aactcagact ttgactgcac tatagtgtca 120 c 121 <210> 7 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (88)..(88) <223> n is a, c, g, or t <400> 7 atcaaataac ttgatggttt ctgaggaatc ccatgatgtc aaatccgttt tattagctaa 60 Page 3 SEMB012USP1_ST25 mgcaaatgac cagtgcaatt tagccatntc aaaatgttgc tgtccaagtg caagtaaccc 120 t 121 <210> 8 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 8 tgaatcagaa ggttctcttt gtgcaatttg tatccctggc atactataat atacgaaatg 60 waatcatctc ttataacctg gtaggacata ggtagaaaat ctaactggat gattagccaa 120 t 121 <210> 9 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (86)..(86) <223> n is a, c, g, or t <220> <221> misc_feature <222> (102)..(102) <223> n is a, c, g, or t <400> 9 gcttgaaaac atagttaagc aactttttcc tcaagctggt tgtcaatctt ggtcacctag 60 ratggtacag ccgatttgga aaacantatg ggaaactaaa antgcacaat tgagagaagg 120 t 121 <210> 10 <211> 121 <212> DNA <213> Artificial sequence Page 4 SEMB012USP1_ST25 <220> <223> Marker sequence <400> 10 ttccattgct tctctgcctt tgatctcctt ccatttcttc agccctactt tgtcacgatt 60 stcaaagcta gggttagttt tacttttgaa ttcgattttg aattcttaat tcttatgatt 120 t 121 <210> 11 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (13)..(13) <223> n is a, c, g, or t <400> 11 tctggattga aanttaatgg cagcaaggtt gagaaagctg aagagaaggt ggaaaagatg 60 yctgctttga cgctgaaacc agagaaggtt aaagatgcat cgaaggctga ggctgttgtc 120 a 121 <210> 12 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (105)..(106) <223> n is a, c, g, or t <400> 12 aatgacagta aaatggaaaa ttgttcaggt ttgagcctgc ggcatcatgc cctccaaata 60 yggagtccat tttaacaatc cttatttaga attactttgg taaannaagc agagagatta 120 Page 5 SEMB012USP1_ST25 a 121 <210> 13 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 13 tttggaattt ataataggta gtgaaaagaa atgtctgaat tcagagctct ggcatgcatg 60 ygctggacct cttgtatgtt tgccaacaat cgggactcga gtagtttact tccctcaagg 120 c 121 <210> 14 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (9)..(9) <223> n is a, c, g, or t <220> <221> misc_feature <222> (15)..(15) <223> n is a, c, g, or t <220> <221> misc_feature <222> (94)..(94) <223> n is a, c, g, or t <400> 14 ttcatgcang catanattga tgtatgttgt atgtaaacaa taacagtaag ttttgtgttg 60 ytattgtagg tggagggaga atgcgaaaga agcngttgaa gaactgggag ttgctttgaa 120 a 121 Page 6 SEMB012USP1_ST25 <210> 15 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (91)..(91) <223> n is a, c, g, or t <400> 15 caatcccacc tacacacaca tttccacacg ttgcattttg tgagtttata tactttctgt 60 ygttatcttc atagtcaacc ttgcttattt naacaataat ataaaagtgc ttttggtaaa 120 a 121 <210> 16 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 16 tctttcgaat gtgtattctg aagtgaacag atgggatgat gcagagacga cgaggattag 60 yatgaagaat tgtaatgtag ataaattgcc tggatggagt tgtatagagg ttaatggaaa 120 g 121 <210> 17 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (5)..(5) <223> n is a, c, g, or t Page 7 SEMB012USP1_ST25 <220> <221> misc_feature <222> (104)..(104) <223> n is a, c, g, or t <220> <221> misc_feature <222> (115)..(115) <223> n is a, c, g, or t <400> 17 caaancatag ccaacctctg ccagtaagtt caactaccct ccaagcacta cctttcacct 60 rcactacagc tacttcacct tcttctacct tctgcccgca aatnccatca ctacnccaac 120 c 121 <210> 18 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 18 ggcttatgac caggcagctt ttgccatgag ggggtcgctg gcaattttga acttctcagt 60 sgaaacagtt gttgaatctt tgagagaagt caagtgccta aaagctggag gagagtcccc 120 t 121 <210> 19 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (11)..(11) <223> n is a, c, g, or t <220> <221> misc_feature <222> (95)..(95) <223> n is a, c, g, or t Page 8 SEMB012USP1_ST25 <400> 19 gcttcagaaa nccttaagtt ttatttcttc tgcatcatca ccccctcttc cctatagttc 60 sgattactat attcccgccg tacaatttcc gaaancacct ccaaatctta ccgtttctca 120 a 121 <210> 20 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (34)..(34) <223> n is a, c, g, or t <400> 20 ggcttatgac caggcagctt ttgccatgag gggntcgctg gcaattttga acttctcagt 60 sgaaacagtt gttgaatctt tgagagaagt caagtgccta aaagctggag gagagtcccc 120 t 121 <210> 21 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (6)..(6) <223> n is a, c, g, or t <400> 21 agaaangaag aagaaaaaca atcgaatccc ctacctctta tcagaacatc gacccgaacc 60 scacaaacca cccaatattc cattgcctca tcaaaaattg cctcgccgcc ttcacccaga 120 a 121 Page 9 SEMB012USP1_ST25 <210> 22 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (9)..(9) <223> n is a, c, g, or t <400> 22 aattaaaant aaatggatca cagacattag tatgaaagca agcaatatat aattagaatt 60 yagggctgtt ttgctagaaa tttgagtttt gcatcttgca ttttcaatat gcatgttaaa 120 a 121 <210> 23 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (12)..(12) <223> n is a, c, g, or t <400> 23 cctaaccatg gnatttgtcc agctaagatc cccttcaaga gcaagattct caatatttag 60 yattagcggt ttcccaaact acactcaaga tcagggcagg ccctgtatac tgggttgctc 120 t 121 <210> 24 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence Page 10 SEMB012USP1_ST25 <400> 24 ttaataaact gaaaaggagg attcattcat tcatgttaaa gtgcataaaa taatagatga 60 ygatgacgat gatgatttgg ttttcgattt tcttaccctt gcaaaagctc gagaagctgt 120 g 121 <210> 25 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (4)..(4) <223> n is a, c, g, or t <220> <221> misc_feature <222> (19)..(19) <223> n is a, c, g, or t <400> 25 aaangagaag agaaaaaanc atgcccctta tcttgctatt tatctcattt aatctcttaa 60 ytactgcatc cgcatctgat gcagaggaat cccttcttaa ctggagatcg tctcttataa 120 a 121 <210> 26 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 26 atttcgttct aaggatgggg agtggcactg ttatgtggat aatgctgtct ggtactatgc 60 yatgttatta gttggtgaca gttatattat catacactac aaaaattgca tgggttaatt 120 g 121 Page 11 SEMB012USP1_ST25 <210> 27 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 27 aattcctcgg agatggatat tcttctctgt aaatagcctc gagattaaat ggcctaaatc 60 raaacccatt aacatatgat atccaacaaa caaagtagga cccacagatg gaattccttc 120 a 121 <210> 28 <211> 315 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 28 gtattcaagt tggcccacgt ttcctcaact ttatattgat ggggagtttt atggagggtg 60 tgatattact gttgaagcat accagagtgg ggaactgcag gaagcaatag aaaaagcaat 120 gtgttcttaa taatgtctca gttatarcct tctatgctcc attcatgcaa agttacactt 180 atttattaat tatgttatta tataatatat atctgcaatt ttcatatttc agatctgtgg 240 atgacactta ccatttagtt gcttctggtg tttatattta ttctacaaag accatttact 300 gagttttcaa atgct 315 <210> 29 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (23)..(23) <223> n is a, c, g, or t Page 12 SEMB012USP1_ST25 <220> <221> misc_feature <222> (99)..(99) <223> n is a, c, g, or t <220> <221> misc_feature <222> (104)..(104) <223> n is a, c, g, or t <220> <221> misc_feature <222> (114)..(114) <223> n is a, c, g, or t <400> 29 catcttataa gtaatatact ttnaactttt aaggatcttc aaatattctc ttataaatta 60 raggccccaa gattaatcca aactgaattc ataaacaant aaantatcta tttnagtttc 120 t 121 <210> 30 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (58)..(58) <223> n is a, c, g, or t <400> 30 aagctgtgat ttgtgcacac tggtgtgcag gtgcactgtg gatagtagca gttgtttnat 60 ygggtgatgg ctagtttgga ctgtggtcat taatgtttag aggctaaagc agctggttga 120 a 121 <210> 31 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence Page 13 SEMB012USP1_ST25 <220> <221> misc_feature <222> (7)..(7) <223> n is a, c, g, or t <220> <221> misc_feature <222> (33)..(33) <223> n is a, c, g, or t <220> <221> misc_feature <222> (97)..(97) <223> n is a, c, g, or t <400> 31 aaattantta ctgtaaattc atcaaaccct aantcaatca tgcaagtgtg caattacacc 60 rctcaagtcc caccatcata caatacttat cgatttngat gactttcaaa gtttagtgct 120 a 121 <210> 32 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 32 tttgaagcgg aaagatatgt ctgttgtggt gtcaatgcgc ataataaaga aagcatcaaa 60 kgggtaacta ctatttcaaa attcatgtat tcaatcatat tgtttatggg ctttcgtcgt 120 g 121 <210> 33 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature Page 14 SEMB012USP1_ST25 <222> (21)..(21) <223> n is a, c, g, or t <220> <221> misc_feature <222> (106)..(106) <223> n is a, c, g, or t <400> 33 ttactattaa tatcatccat ntaaactgtt acgtcatttc gaaattttca tctcactaaa 60 mggtgcaaat tgatatgatc catcgaaaat atttatttaa ccatcnattt caaacgtagt 120 t 121 <210> 34 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (16)..(16) <223> n is a, c, g, or t <400> 34 ttgtcctaac ccctanatca tatagtatct gtgctccaat gccatattct cgtgaatcaa 60 yaggtaaccc caaatcttcg ttggcttcca cagtgtcacg gccagcatct tgcagattat 120 a 121 <210> 35 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 35 cactaaagga tctgagcaaa cagctgtaga agttaatgat agtgaaagtg atttgaaccg 60 racaattttc ataaacaata ttccatttga tgctgacagt gaagaggtga aaaagagatt 120 c 121 Page 15 SEMB012USP1_ST25 <210> 36 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (16)..(16) <223> n is a, c, g, or t <400> 36 tgcagatcca agtaantatg gtatttttaa attgatagct atcgattatt ttggaccttt 60 yctcttttct gcatttgatg attgcaaatg tgttctgata ttattatttt tcatattttt 120 a 121 <210> 37 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (86)..(86) <223> n is a, c, g, or t <400> 37 tttgatgcgc ctaggacccc aacttaaaga aagccacttt gaacgtgaga atgattctgc 60 rtatagttca tcatttagca tccccnttca caaataatgc aaaacttcat tctcagattg 120 c 121 <210> 38 <211> 121 <212> DNA <213> Artificial sequence <220> Page 16 SEMB012USP1_ST25 <223> Marker sequence <400> 38 cgcttggcat cagtacagta gttgtaaatc atgaacttcc tctgcaccca cctcattctc 60 ytgtaactca ccgaatccaa ctcgtggtta taccaatctg ctggcgaagc cgttgacaac 120 a 121 <210> 39 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (2)..(2) <223> n is a, c, g, or t <220> <221> misc_feature <222> (60)..(60) <223> n is a, c, g, or t <400> 39 anttaaggga gtttgtgtaa atatcaacaa ggatacgtag tccatcacta ctgtcatggn 60 rgttagacgc tccggctttg gtcagtgaag ttacaggttg aatcatggta gtgtcattca 120 a 121 <210> 40 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 40 ataaattggg atcagccaga aaatgctgaa acacacctat caacaattta taccagaatc 60 rctatttaca gccaacatgc tagaggcact tcaataaaat gtttagacag atcagtcatt 120 t 121 Page 17 SEMB012USP1_ST25 <210> 41 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 41 aagaattcac ttgttgatag cttcattgtc ttgctggttt tcaactaatc tcatattcta 60 rgttgccctg aaattaaatg taaatgggaa aaatgtgaaa aggcaggtta gaatcttata 120 c 121 <210> 42 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 42 ctcaataggc tttcttggtg aggcagagta atcggcatgt cttcttggtg aagcagagtg 60 rtcagtttgc cttcttggtg caggagagta cgaccttgat gtatggcgag ctcttgaaga 120 t 121 <210> 43 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (10)..(10) <223> n is a, c, g, or t <400> 43 taggtaaaan ttaaagagaa aagcatcgta aataattaag tcacaaagca gcaggtgtgt 60 mgagtctaca ctaaaccaat cctttaagaa gtgtaccact tatatacgat taaatgtatt 120 Page 18 SEMB012USP1_ST25 a 121 <210> 44 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 44 cctaattttt ctcctcaaat atcccatttg tttctaacta aatctcaaag gaaaagcttt 60 yattgcacga taacggttaa tttaatcatt cttcaagcta cacaatcagt caatcagtcg 120 t 121 <210> 45 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (34)..(34) <223> n is a, c, g, or t <400> 45 aatttcgcga tgcatttgag attgttgtgg aaantatggt gcgtatggtc accaaatgag 60 rtatacacga ttcctttgta acgataaatg tttggatgac attcaattgt agaaccactg 120 a 121 <210> 46 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature Page 19 SEMB012USP1_ST25 <222> (118)..(118) <223> n is a, c, g, or t <400> 46 aatcttccaa atggtctaag ttatacaacc ttaaagagca gccatatgat tcatgtatat 60 ygactgagat aaaatggaaa ggtgcaagtg gtggtggaaa ttataaacat tgcaaccntc 120 a 121 <210> 47 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 47 ttctattatt aataaaaaga atactattat ccttaaatca acaatcttgg aatcctttag 60 ygaggcaaag ttaccgagtt tcgtttctct tgaacttgtt acaataatta caaaaccata 120 c 121 <210> 48 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 48 catttttaaa tattggtaat atgcaaacat attttaagaa aatgccaagt agatgagcca 60 yagaagatac attcaatgtc tccaatgtag atttatttat tttttttaaa acaagagaat 120 a 121 <210> 49 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 49 Page 20 SEMB012USP1_ST25 atgtgttgtt agatctgctt tctaattctc aggatcgaaa gtccaatttc ttgctacctt 60 wtaaaagagc taccaacgac agcattcaag ctgttaatga agaagatgac acatcacgtc 120 c 121 <210> 50 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 50 gtctctgtat aaccagcctg gtgccgctgg agctcctggt ggggctgact cagctggacc 60 kgtgcctggt tcggaacctt ctggaacttc gggtggtaag gggctgaaga tggtgatgtt 120 a 121 <210> 51 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 51 aggagttttg ggcgacggga gtgagattgc cgtgaagaaa gtactggaat cagatctcca 60 ygatgatgaa ttcaagaatg aggttgagat aatcagcaag ttaaggcata gaaatcttgt 120 t 121 <210> 52 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (24)..(24) <223> n is a, c, g, or t Page 21 SEMB012USP1_ST25 <400> 52 agccacaaca atagaccaaa atgnatttgc ttcttttgca tgacaatata aagatgatgc 60 wtgcttcttc aaccaggcag cacaaggatg acctgttcca tcgaagttat ttttaccact 120 t 121 <210> 53 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 53 ttcattcagg tatttatcat ctctgtggag tgctagcgca tgaccgataa agtcaattgt 60 rttgtcatcc aatccatatt ttgatatgag ctctttagta gtcacccttg taaggtccaa 120 t 121 <210> 54 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 54 cctctgaaat taagatactt tctggagtag aaacaagtga agctgctact gtttcaggta 60 ytggcagcga ttcttcttcg tcagaactat taccttcgga ttcttcttct attgggtttt 120 c 121 <210> 55 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 55 gaaaaagacg acgaatctgc attttcgtcc tgaaagttaa cgatcgccag ccgcctatca 60 Page 22 SEMB012USP1_ST25 ycctcagctt cttcgacgtc gccaagggaa ggtgaagaat cgaactcgac gtcggagtct 120 g 121 <210> 56 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (12)..(12) <223> n is a, c, g, or t <400> 56 tattggtaaa antaagtaca aaatataaga agattaagtt taataatcct ggttccttta 60 wattgtccag actctcccaa gcaaaacaag tgagaaatta gcattggctt caaagttcaa 120 a 121 <210> 57 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (26)..(26) <223> n is a, c, g, or t <220> <221> misc_feature <222> (52)..(52) <223> n is a, c, g, or t <220> <221> misc_feature <222> (84)..(84) <223> n is a, c, g, or t <400> 57 Page 23 SEMB012USP1_ST25 gattagattt cgagaatgga gaaaanggga gtgttggaag aaacagtaaa anggaataag 60 ygtaggtgac cgttggagat tttngtttat aaaatgctga tttacgatta agctttagcc 120 a 121 <210> 58 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 58 tggtatacaa atacagctcg atattggtta ctaattgctt gatattggta tggtaatacc 60 rtaatagccc taactagctc taggtctaaa atttatcttt tcatggaaaa tgacatagtt 120 t 121 <210> 59 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 59 agattgtgtg tttcctagga ttcctcagtt agcagttatt ggtttttcgg gtagtcttgc 60 kaatctttac acgtttgaga taaggtcaat gtgggtggct cattttcttg atggagggtt 120 t 121 <210> 60 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (87)..(87) <223> n is a, c, g, or t Page 24 SEMB012USP1_ST25 <220> <221> misc_feature <222> (90)..(90) <223> n is a, c, g, or t <400> 60 gccctgctcc agagcttatt ctcacgactg gacggagtgc cctttcgtgc atccaggcga 60 raacgcgcgt cgaagagact tgaaaangtn cgtctacagc tgcgttccgt gtcctgagtt 120 c 121 <210> 61 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (12)..(12) <223> n is a, c, g, or t <400> 61 tattaaagtt tngtccaaaa gaaggcgata gtggatcaac tgaatatcca acaagtccat 60 rgttattgtt gttattacga taattggatg gagagcttcc acctggactg ccaattaaag 120 a 121 <210> 62 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 62 tgccttccag cataaacacc cctgcacaaa atgctacatt tgttaggacg tgtcttgcta 60 ytgagcaaaa atacccaaat tggttgactc agttgcctcc aaatgataat aataataaaa 120 c 121 Page 25 SEMB012USP1_ST25 <210> 63 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 63 aactgtagta cagaaataaa ctagtctgaa cccatgcttc gcacatggaa tcgcacaaca 60 ygattaaata aaatttgcat agtacatttc aggtttgcga tgtttgacaa atacatcaga 120 t 121 <210> 64 <211> 116 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (57)..(57) <223> n is a, c, g, or t <220> <221> misc_feature <222> (75)..(75) <223> n is a, c, g, or t <400> 64 ctatagtgca gagcttgaac ttgaaccaaa gcagtatcat gtaattgcat ttgaarntcc 60 agcagattct aaaantttct gttatattgt gcaagcacat atggagatgt taggaa 116 <210> 65 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 65 tcaggttgga gcggacccgg aaagtgcagc cgcctacaat ggaggtttgg ttaggaagtt 60 Page 26 SEMB012USP1_ST25 yaatggtgga ggagggacgc cgttgatgcc gaagaggaag tttgagacgt acatttttgc 120 g 121 <210> 66 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 66 caatgagaca tagccaattg gcatttcgca gcactgacct aaaatggatt cataatcaaa 60 yccttctaaa ggcaaaccat tcaaacttct attagtgatt ctctttacgg cctcacgtcg 120 a 121 <210> 67 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (26)..(26) <223> n is a, c, g, or t <400> 67 acaattgcta tcttcgtttt tacatnaccg tttggtggtc gataacatag atgaatgaaa 60 ygaggaggat ttgatgaagc agcagcaaca cctaaatatg aacccatctt caattccgtg 120 c 121 <210> 68 <211> 235 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 68 Page 27 SEMB012USP1_ST25 tgtggattag ctactaaaaa ttatacatga tttcaggaaa tgaagcacat tattcaatca 60 taaagcaagc tcagctggtt cacctggatk asgtkystgt saarmwymmm twmwscyryt 120 kaaccmtmcy mwmkyrrmmk krykwtasay akgcykkkcy ywykmygwrw ymwttymykm 180 kmwrscyrww wwrmytmkkm mkmwyyaymc kmmmyrttwm aykyykywrc gactc 235 <210> 69 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (97)..(97) <223> n is a, c, g, or t <400> 69 agatataact acttttggat tatgggctta tgatgctgct tttgccttag caatggctac 60 ygagtcagct cagccagctt ataactatag taatgangtt gctaacggta atttaatgaa 120 g 121 <210> 70 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (92)..(92) <223> n is a, c, g, or t <400> 70 agaaattaca gttgataaag tagccgatga aggcaatctt acactagcac aaagttttag 60 ygataaccac agtgataggg attcaagaaa ancactggct cacttaacaa tgagcaaatc 120 t 121 Page 28 SEMB012USP1_ST25 <210> 71 <211> 141 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (55)..(55) <223> n is a, c, g, or t <400> 71 gcattccata accaccattc aacatgcact ccactggcat gcaatatgtt attanatttt 60 atgatcaagy actttcatca gctgttacaa gttgtgactg ttcgctgcta ataacttaat 120 aattctgtca ctacaacaaa t 141 <210> 72 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (50)..(50) <223> n is a, c, g, or t <220> <221> misc_feature <222> (93)..(93) <223> n is a, c, g, or t <400> 72 tggtgtttct ggagctgaag catttggaga agtattcaca ttgaaggaan taggcatttg 60 macagtgcca tagcaatttg gctcagaacc agncgcacag atcaaaggat ttcctacaat 120 g 121 <210> 73 <211> 121 Page 29 SEMB012USP1_ST25 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <400> 73 tgactctata ctagatgatg agttctcctt ctccaacctc aacttatcac atctgctatt 60 ytgactaaca ttcattgcat cacttctgct tctttgaact ctttgttgca atccaacatt 120 c 121 <210> 74 <211> 121 <212> DNA <213> Artificial sequence <220> <223> Marker sequence <220> <221> misc_feature <222> (11)..(11) <223> n is a, c, g, or t <220> <221> misc_feature <222> (24)..(24) <223> n is a, c, g, or t <400> 74 atggcttgaa nggtcgctca tcanccccca gcggtccgac cactctatat ccaatctcct 60 scgcctcgat tatcttctcc tctttactct tcccactcac tttaaacttc ctcacggatc 120 c 121 <210> 75 <211> 20 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 75 agctctactc ttccagcaaa 20 Page 30 SEMB012USP1_ST25 <210> 76 <211> 20 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 76 atgatccaat gcttttccat 20 <210> 77 <211> 18 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 77 tcacttctga taaagctt 18 <210> 78 <211> 17 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 78 ccttggagag tgttgtc 17 <210> 79 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 79 atcattggga aataatcat 19 <210> 80 <211> 19 <212> DNA Page 31 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 80 ctggtcattt gctttagct 19 <210> 81 <211> 18 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 81 atacgaaatg aaatcatc 18 <210> 82 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 82 ttggtcacct agaatggta 19 <210> 83 <211> 17 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 83 ctagctttga gaatcgt 17 <210> 84 <211> 16 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe Page 32 SEMB012USP1_ST25 <400> 84 atggactcca tatttg 16 <210> 85 <211> 15 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 85 tccagcacat gcatg 15 <210> 86 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 86 ccacctacaa taacaacac 19 <210> 87 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 87 actttctgtt gttatcttc 19 <210> 88 <211> 20 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 88 acaattcttc atactaatcc 20 Page 33 SEMB012USP1_ST25 <210> 89 <211> 17 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 89 cttctcagtc gaaacag 17 <210> 90 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 90 ccctatagtt ccgattact 19 <210> 91 <211> 17 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 91 cttctcagtc gaaacag 17 <210> 92 <211> 15 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 92 ccgaacccca caaac 15 <210> 93 <211> 16 <212> DNA Page 34 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 93 acagccctaa attcta 16 <210> 94 <211> 18 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 94 accgctaata ctaaatat 18 <210> 95 <211> 17 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 95 catcgtcatc atcatct 17 <210> 96 <211> 18 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 96 cggatgcagt aattaaga 18 <210> 97 <211> 21 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe Page 35 SEMB012USP1_ST25 <400> 97 tgttaatggg ttttgattta g 21 <210> 98 <211> 20 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 98 agcatagaag gttataactg 20 <210> 99 <211> 20 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 99 atttcagggc aacttagaat 20 <210> 100 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 100 tgaagcagag tgatcagtt 19 <210> 101 <211> 15 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 101 tcgtgcaata aaagc 15 Page 36 SEMB012USP1_ST25 <210> 102 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 102 caccaaatga gatatacac 19 <210> 103 <211> 17 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 103 ctttgcctca ctaaagg 17 <210> 104 <211> 15 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 104 caggcacagg tccag 15 <210> 105 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 105 tcagatctcc atgatgatg 19 <210> 106 <211> 17 <212> DNA Page 37 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 106 aagatgatgc atgcttc 17 <210> 107 <211> 17 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 107 tcgctgccaa tacctga 17 <210> 108 <211> 20 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 108 caagaaatga gcagtaatat 20 <210> 109 <211> 15 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 109 ccgccatagc tctaa 15 <210> 110 <211> 20 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe Page 38 SEMB012USP1_ST25 <400> 110 tgaaagtgtg tcatcaatta 20 <210> 111 <211> 15 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 111 cctggattag gcctg 15 <210> 112 <211> 18 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 112 caatggctac tgagtcag 18 <210> 113 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 113 actgtggtta tcactaaaa 19 <210> 114 <211> 19 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 114 ctgatgaaag tgcttgatc 19 Page 39 SEMB012USP1_ST25 <210> 115 <211> 16 <212> DNA <213> Artificial sequence <220> <223> VIC‐labeled probe <400> 115 gagttacctc ttagct 16 <210> 116 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 116 ctctactctt gcagcaaa 18 <210> 117 <211> 19 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 117 tgatccaatg ctcttccat 19 <210> 118 <211> 16 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 118 acttctgatg aagctt 16 <210> 119 <211> 15 <212> DNA Page 40 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 119 ttggagagcg ttgtc 15 <210> 120 <211> 17 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 120 cattgggaag taatcat 17 <210> 121 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 121 tggtcatttg cgttagct 18 <210> 122 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 122 atacgaaatg taatcatc 18 <210> 123 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe Page 41 SEMB012USP1_ST25 <400> 123 tggtcaccta ggatggta 18 <210> 124 <211> 17 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 124 ctagctttga caatcgt 17 <210> 125 <211> 16 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 125 atggactccg tatttg 16 <210> 126 <211> 13 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 126 cagcgcatgc atg 13 <210> 127 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 127 cacctacaat agcaacac 18 Page 42 SEMB012USP1_ST25 <210> 128 <211> 16 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 128 ttctgtcgtt atcttc 16 <210> 129 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 129 aattcttcat gctaatcc 18 <210> 130 <211> 16 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 130 ttctcagtgg aaacag 16 <210> 131 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 131 cctatagttc ggattact 18 <210> 132 <211> 16 <212> DNA Page 43 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 132 ttctcagtgg aaacag 16 <210> 133 <211> 14 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 133 cgaaccgcac aaac 14 <210> 134 <211> 14 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 134 agccctgaat tcta 14 <210> 135 <211> 16 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 135 cgctaatgct aaatat 16 <210> 136 <211> 17 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe Page 44 SEMB012USP1_ST25 <400> 136 catcgtcatc gtcatct 17 <210> 137 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 137 cggatgcagt agttaaga 18 <210> 138 <211> 17 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 138 aatgggtttc gatttag 17 <210> 139 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 139 catagaaggc tataactg 18 <210> 140 <211> 17 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 140 tcagggcaac ctagaat 17 Page 45 SEMB012USP1_ST25 <210> 141 <211> 17 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 141 aagcagagtg gtcagtt 17 <210> 142 <211> 15 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 142 tcgtgcaatg aaagc 15 <210> 143 <211> 19 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 143 caccaaatga ggtatacac 19 <210> 144 <211> 16 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 144 tttgcctcgc taaagg 16 <210> 145 <211> 14 <212> DNA Page 46 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 145 aggcaccggt ccag 14 <210> 146 <211> 17 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 146 agatctccac gatgatg 17 <210> 147 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 147 aaagatgatg cttgcttc 18 <210> 148 <211> 16 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 148 cgctgccagt acctga 16 <210> 149 <211> 19 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe Page 47 SEMB012USP1_ST25 <400> 149 aagaaatgag cggtaatat 19 <210> 150 <211> 14 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 150 cgccatggct ctaa 14 <210> 151 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 151 aaagtgtgtc gtcaatta 18 <210> 152 <211> 16 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 152 cctggatgac ttgtgt 16 <210> 153 <211> 17 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 153 aatggctacc gagtcag 17 Page 48 SEMB012USP1_ST25 <210> 154 <211> 18 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 154 ctgtggttat cgctaaaa 18 <210> 155 <211> 19 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 155 ctgatgaaag tacttgatc 19 <210> 156 <211> 15 <212> DNA <213> Artificial sequence <220> <223> FAM‐labeled probe <400> 156 ttggagcata cccta 15 <210> 157 <211> 29 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 157 tttgtaacca aactctgacc ttagatgtt 29 <210> 158 <211> 22 <212> DNA Page 49 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> Taqman forward primer <400> 158 gacgaaggtg atgatgcttt gc 22 <210> 159 <211> 18 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 159 cggaaggtcg cgatcctc 18 <210> 160 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 160 ggacgatgcg atcaagacta caaat 25 <210> 161 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 161 gtcctctagc tcttttcggt gtag 24 <210> 162 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer Page 50 SEMB012USP1_ST25 <400> 162 gaatcccatg atgtcaaatc cgttt 25 <210> 163 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 163 tgtgcaattt gtatccctgg cata 24 <210> 164 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 164 ctttttcctc aagctggttg tcaat 25 <210> 165 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 165 tccatttctt cagccctact ttgtc 25 <210> 166 <211> 17 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 166 gagcctgcgg catcatg 17 Page 51 SEMB012USP1_ST25 <210> 167 <211> 26 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 167 agaaatgtct gaattcagag ctctgg 26 <210> 168 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 168 attgatgtat gttgtatgta aacaataaca gtaagt 36 <210> 169 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 169 acatttccac acgttgcatt ttgt 24 <210> 170 <211> 23 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 170 gaacagatgg gatgatgcag aga 23 <210> 171 <211> 20 <212> DNA Page 52 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> Taqman forward primer <400> 171 gggtcgctgg caattttgaa 20 <210> 172 <211> 20 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 172 ctgcatcatc accccctctt 20 <210> 173 <211> 22 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 173 cttatgacca ggcagctttt gc 22 <210> 174 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 174 cccctacctc ttatcagaac atcga 25 <210> 175 <211> 27 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer Page 53 SEMB012USP1_ST25 <400> 175 tcacagacat tagtatgaaa gcaagca 27 <210> 176 <211> 23 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 176 ccccttcaag agcaagattc tca 23 <210> 177 <211> 30 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 177 gaggattcat tcattcatgt taaagtgcat 30 <210> 178 <211> 28 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 178 catgcccctt atcttgctat ttatctca 28 <210> 179 <211> 31 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 179 gatattcttc tctgtaaata gcctcgagat t 31 Page 54 SEMB012USP1_ST25 <210> 180 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 180 ctgcaggaag caatagaaaa agcaa 25 <210> 181 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 181 gcttcattgt cttgctggtt ttcaa 25 <210> 182 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 182 gcagagtaat cggcatgtct tctt 24 <210> 183 <211> 33 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 183 cccatttgtt tctaactaaa tctcaaagga aaa 33 <210> 184 <211> 25 <212> DNA Page 55 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> Taqman forward primer <400> 184 cgatgcattt gagattgttg tggaa 25 <210> 185 <211> 35 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 185 taaaaagaat actattatcc ttaaatcaac aatct 35 <210> 186 <211> 17 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 186 cgctggagct cctggtg 17 <210> 187 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 187 attgccgtga agaaagtact ggaa 24 <210> 188 <211> 23 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer Page 56 SEMB012USP1_ST25 <400> 188 agccacaaca atagaccaaa atg 23 <210> 189 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 189 ggagtagaaa caagtgaagc tgcta 25 <210> 190 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 190 aggaagttga aaaggccatt aacga 25 <210> 191 <211> 23 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 191 cgagtgctcc ctcatgtatt tgg 23 <210> 192 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 192 ccttgagtac ctaggtgact atcgt 25 Page 57 SEMB012USP1_ST25 <210> 193 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 193 aagagtaaga ggttaaacgg gttgc 25 <210> 194 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 194 gcttatgatg ctgcttttgc cttag 25 <210> 195 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 195 cgatgaaggc aatcttacac tagca 25 <210> 196 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 196 actccactgg catgcaatat gttat 25 <210> 197 <211> 29 <212> DNA Page 58 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> Taqman forward primer <400> 197 agtagaaata agtgaagaat attgatgtg 29 <210> 198 <211> 23 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 198 ggttggagat ccaaattgct atc 23 <210> 199 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 199 gctaggctgg taggttcttt tagt 24 <210> 200 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 200 gagctagctt ggtaacaaga ggatt 25 <210> 201 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer Page 59 SEMB012USP1_ST25 <400> 201 ggtaatggta ttctccaacc ttggt 25 <210> 202 <211> 26 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 202 cactatagtg cagtcaaagt ctgagt 26 <210> 203 <211> 23 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 203 gcacttggac agcaacattt tga 23 <210> 204 <211> 30 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 204 ttagattttc tacctatgtc ctaccaggtt 30 <210> 205 <211> 19 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 205 accttctctc aattgtgca 19 Page 60 SEMB012USP1_ST25 <210> 206 <211> 39 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 206 aaatcataag aattaagaat tcaaaatcga attcaaaag 39 <210> 207 <211> 31 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 207 tttaccaaag taattctaaa taaggattgt t 31 <210> 208 <211> 21 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 208 gagtcccgat tgttggcaaa c 21 <210> 209 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 209 caaagcaact cccagttctt caac 24 <210> 210 <211> 30 <212> DNA Page 61 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> Taqman reverse primer <400> 210 ttttaccaaa agcactttta tattattgtt 30 <210> 211 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 211 ctctatacaa ctccatccag gcaat 25 <210> 212 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 212 gcttttaggc acttgacttc tctca 25 <210> 213 <211> 23 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 213 cggaaattgt acggcgggaa tat 23 <210> 214 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer Page 62 SEMB012USP1_ST25 <400> 214 gcttttaggc acttgacttc tctca 25 <210> 215 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 215 ggcaattttt gatgaggcaa tggaa 25 <210> 216 <211> 28 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 216 gcaagatgca aaactcaaat ttctagca 28 <210> 217 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 217 gccctgatct tgagtgtagt ttgg 24 <210> 218 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 218 gcaagggtaa gaaaatcgaa aacca 25 Page 63 SEMB012USP1_ST25 <210> 219 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 219 cagttaagaa gggattcctc tgcat 25 <210> 220 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 220 tgggtcctac tttgtttgtt ggat 24 <210> 221 <211> 35 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 221 aacataatta ataaataagt gtaactttgc atgaa 35 <210> 222 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 222 cctgcctttt cacatttttc ccatt 25 <210> 223 <211> 20 <212> DNA Page 64 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> Taqman reverse primer <400> 223 gtcgtactct cctgcaccaa 20 <210> 224 <211> 27 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 224 tgattgactg attgtgtagc ttgaaga 27 <210> 225 <211> 30 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 225 gtcatccaaa catttatcgt tacaaaggaa 30 <210> 226 <211> 26 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 226 agttcaagag aaacgaaact cggtaa 26 <210> 227 <211> 21 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer Page 65 SEMB012USP1_ST25 <400> 227 cacccgaagt tccagaaggt t 21 <210> 228 <211> 27 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 228 gccttaactt gctgattatc tcaacct 27 <210> 229 <211> 19 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 229 ccttgtgctg cctggttga 19 <210> 230 <211> 26 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 230 tccgaaggta atagttctga cgaaga 26 <210> 231 <211> 29 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 231 ctttttgaac catttctttt ctcctgtct 29 Page 66 SEMB012USP1_ST25 <210> 232 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 232 cctaccaaaa cgccaaagaa ttaca 25 <210> 233 <211> 33 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 233 tcttgaatct ctctgttaat agttcaaatc gtg 33 <210> 234 <211> 30 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 234 aattatacat gatttcagga aatgaagcac 30 <210> 235 <211> 28 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 235 tcattactat agttataagc tggctgag 28 <210> 236 <211> 23 <212> DNA Page 67 SEMB012USP1_ST25 <213> Artificial sequence <220> <223> Taqman reverse primer <400> 236 gctcattgtt aagtgagcca gtg 23 <210> 237 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 237 agcgaacagt cacaacttgt aaca 24 <210> 238 <211> 24 <212> DNA <213> Artificial sequence <220> <223> Taqman reverse primer <400> 238 tggtttgagc ttgttggttt ggag 24 <210> 239 <211> 28 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer <400> 239 atcattttag ccatatcgta aattgtca 28 <210> 240 <211> 25 <212> DNA <213> Artificial sequence <220> <223> Taqman forward primer Page 68 SEMB012USP1_ST25 <400> 240 tacaatatga tacagaaaat cagag 25 Page 69